Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS3W
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W -0.9 %
2W 2.3 %
1M 8.0 %
3M 5.5 %
6M 16.9 %
9M 4.7 %
1Y -67.1 %
Alpha
-81.6%
Beta
0.66
sharpe-R
-0.94
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
1.8
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2025-02-18 07:01:04
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -76.05%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 10% -9.54%
UTMD Utah Medical Products, Inc. Sell -5.16% 0.42%
AADI Aadi Bioscience, Inc. Sell -4.64% 10.38%
The percentage of cash held in the portfolio is: 99.8%
** The description of each asset is available Here

The latest 5 Compositions change

2025-02-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 10% -9.54%
UTMD Utah Medical Products, Inc. Sell -5.16% 0.42%
AADI Aadi Bioscience, Inc. Sell -4.64% 10.38%
The percentage of cash held in the portfolio is: 99.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
HROW Buy All NA
Assets Rebalanced
None
2025-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 11.15% 1.73%
HROW Harrow Health, Inc. Sell -6.75% 3.96%
UTMD Utah Medical Products, Inc. Sell -5.01% 2.37%
AADI Aadi Bioscience, Inc. Sell -4.92% 4.15%
The percentage of cash held in the portfolio is: 105.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLFS Sell All -7.77%
Assets Rebalanced
None
2025-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 15.96% -7.46%
RGNX REGENXBIO Inc. Buy 11.42% 4.46%
HROW Harrow Health, Inc. Sell -6.74% 3.87%
UTMD Utah Medical Products, Inc. Sell -5.01% 2.3%
AADI Aadi Bioscience, Inc. Sell -5.02% 2.08%
The percentage of cash held in the portfolio is: 89.39%
New Assets Added
None
Assets Removed
Asset Action Perf %
HAE Buy All 14.33%
ORGO Sell All 6.61%
NUTX Sell All 54.16%
Assets Rebalanced
None
2025-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.75% 8.11%
NUTX Nutex Health Inc. Buy 15.55% 42.68%
BLFS BioLife Solutions, Inc. Buy 16.55% -5.58%
RGNX REGENXBIO Inc. Buy 11.61% 4.46%
HAE Haemonetics Corporation Sell -6.92% 3.11%
HROW Harrow Health, Inc. Sell -6.82% 4.34%
UTMD Utah Medical Products, Inc. Sell -5.1% 2.14%
AADI Aadi Bioscience, Inc. Sell -5.23% -0.35%
The percentage of cash held in the portfolio is: 68.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDXG Sell All -3.17%
MD Sell All -0.14%
Assets Rebalanced
None
2025-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDXG MiMedx Group, Inc. Buy 11.52% -3.06%
MD Pediatrix Medical Group, Inc. Buy 11.51% -0.64%
ORGO Organogenesis Holdings Inc. Buy 11.58% 4.5%
NUTX Nutex Health Inc. Buy 14.05% 26.47%
BLFS BioLife Solutions, Inc. Buy 16.63% -6.96%
RGNX REGENXBIO Inc. Buy 11.83% 4.46%
HAE Haemonetics Corporation Sell -6.83% 6.27%
HROW Harrow Health, Inc. Sell -6.94% 4.52%
UTMD Utah Medical Products, Inc. Sell -5.19% 2.17%
AADI Aadi Bioscience, Inc. Sell -5.02% 5.54%
The percentage of cash held in the portfolio is: 46.85%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDRX Buy All 47.11%
ACRS Sell All 0.4%
Assets Rebalanced
None
2025-02-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 11.44% -4%
MDXG MiMedx Group, Inc. Buy 11.63% -3.17%
MD Pediatrix Medical Group, Inc. Buy 11.63% -0.57%
ORGO Organogenesis Holdings Inc. Buy 11.46% 2.4%
NUTX Nutex Health Inc. Buy 14.29% 27.3%
BLFS BioLife Solutions, Inc. Buy 16.99% -5.94%
RGNX REGENXBIO Inc. Buy 11.09% -3.1%
HAE Haemonetics Corporation Sell -6.62% 10.04%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.55% 44.44%
HROW Harrow Health, Inc. Sell -6.79% 7.62%
UTMD Utah Medical Products, Inc. Sell -5.24% 2.27%
AADI Aadi Bioscience, Inc. Sell -5.09% 5.19%
The percentage of cash held in the portfolio is: 38.75%
New Assets Added
None
Assets Removed
Asset Action Perf %
INSM Sell All 12.98%
AXGN Sell All -1.81%
SIGA Sell All -9.55%
Assets Rebalanced
None
2025-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
INSM Insmed Incorporated Buy 11.54% 11.1%
AXGN AxoGen, Inc. Buy 12.87% -0.22%
ACRS Aclaris Therapeutics, Inc. Buy 11.69% -0.8%
MDXG MiMedx Group, Inc. Buy 11.71% -1.36%
MD Pediatrix Medical Group, Inc. Buy 11.55% -0.14%
ORGO Organogenesis Holdings Inc. Buy 12.23% 10.51%
NUTX Nutex Health Inc. Buy 13.72% 23.71%
SIGA SIGA Technologies, Inc. Buy 12.31% -6.42%
BLFS BioLife Solutions, Inc. Buy 17.22% -3.5%
RGNX REGENXBIO Inc. Buy 11.31% 0%
HAE Haemonetics Corporation Sell -6.83% 6.09%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.83% 39.33%
HROW Harrow Health, Inc. Sell -6.91% 4.86%
UTMD Utah Medical Products, Inc. Sell -5.29% 0.13%
AADI Aadi Bioscience, Inc. Sell -5.28% 0.35%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RGNX
Assets Removed
Asset Action Perf %
TGTX Sell All -0.69%
Assets Rebalanced
None
2025-01-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
INSM Insmed Incorporated Buy 11.77% 13.16%
AXGN AxoGen, Inc. Buy 12.95% 0.33%
ACRS Aclaris Therapeutics, Inc. Buy 11.13% -5.6%
MDXG MiMedx Group, Inc. Buy 12.19% 2.61%
MD Pediatrix Medical Group, Inc. Buy 11.73% 1.36%
ORGO Organogenesis Holdings Inc. Buy 12.64% 14.11%
NUTX Nutex Health Inc. Buy 12.91% 16.31%
SIGA SIGA Technologies, Inc. Buy 12.9% -2.03%
TGTX TG Therapeutics, Inc. Buy 11.92% 4.54%
BLFS BioLife Solutions, Inc. Buy 17.86% 0%
HAE Haemonetics Corporation Sell -6.76% 7.13%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.35% 15.44%
HROW Harrow Health, Inc. Sell -7.28% -0.19%
UTMD Utah Medical Products, Inc. Sell -5.31% 0%
AADI Aadi Bioscience, Inc. Sell -5.31% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • UTMD
  • AADI
  • BLFS
Assets Removed
Asset Action Perf %
ORMP Buy All 5.46%
AORT Sell All 3.27%
Assets Rebalanced
None
2025-01-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.72% 2.68%
INSM Insmed Incorporated Buy 12.01% 13.83%
AXGN AxoGen, Inc. Buy 13.21% 0.88%
ACRS Aclaris Therapeutics, Inc. Buy 11.44% -4.4%
MDXG MiMedx Group, Inc. Buy 12.38% 2.72%
MD Pediatrix Medical Group, Inc. Buy 12.13% 3.29%
ORGO Organogenesis Holdings Inc. Buy 12.01% 6.91%
NUTX Nutex Health Inc. Buy 12.52% 11.14%
SIGA SIGA Technologies, Inc. Buy 12.96% -2.97%
TGTX TG Therapeutics, Inc. Buy 12.12% 4.79%
ORMP Oramed Pharmaceuticals Inc. Sell -5.31% 5.46%
HAE Haemonetics Corporation Sell -6.92% 6.31%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.7% 11.11%
HROW Harrow Health, Inc. Sell -7.46% -1.27%
The percentage of cash held in the portfolio is: 2.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Buy All 25.71%
Assets Rebalanced
Asset Action Weight
TGTX Sell -7.88%
AXGN Buy 0.48%
SIGA Buy 0.79%
2025-01-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.73% 1.36%
AXGN AxoGen, Inc. Buy 11.7% -1.75%
INSM Insmed Incorporated Buy 12.04% 12.62%
ACRS Aclaris Therapeutics, Inc. Buy 11.88% -2%
MD Pediatrix Medical Group, Inc. Buy 12.48% 4.86%
MDXG MiMedx Group, Inc. Buy 12.06% -1.25%
ORGO Organogenesis Holdings Inc. Buy 12.79% 12.31%
NUTX Nutex Health Inc. Buy 12% 5.09%
SIGA SIGA Technologies, Inc. Buy 11.97% -0.78%
TGTX TG Therapeutics, Inc. Buy 19.35% 0%
FATE Fate Therapeutics, Inc. Sell -4.48% 21.71%
ORMP Oramed Pharmaceuticals Inc. Sell -5.36% 5.88%
HAE Haemonetics Corporation Sell -7.26% 3.05%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.44% 16.33%
HROW Harrow Health, Inc. Sell -7.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HROW
  • TGTX
Assets Removed
Asset Action Perf %
ESPR Sell All -14.96%
Assets Rebalanced
None
2025-01-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.6% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 12.37% -10.26%
AXGN AxoGen, Inc. Buy 11.7% -0.6%
INSM Insmed Incorporated Buy 12.04% 13.85%
ACRS Aclaris Therapeutics, Inc. Buy 12.04% 0.4%
MD Pediatrix Medical Group, Inc. Buy 12.04% 2.29%
MDXG MiMedx Group, Inc. Buy 12.04% -0.34%
ORGO Organogenesis Holdings Inc. Buy 12.04% 6.91%
NUTX Nutex Health Inc. Buy 12.47% 10.49%
SIGA SIGA Technologies, Inc. Buy 12.04% 0.94%
FATE Fate Therapeutics, Inc. Sell -4.3% 24%
ORMP Oramed Pharmaceuticals Inc. Sell -5.37% 4.62%
HAE Haemonetics Corporation Sell -7.13% 3.69%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.57% 13.33%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
TGTX Buy All -11.64%
Assets Rebalanced
Asset Action Weight
AXGN Sell -1.98%
ACRS Sell -1.81%
INSM Sell -3.64%
ORGO Sell -23.86%
NUTX Buy 1.71%
SIGA Buy 4.12%
MD Buy 9.28%
MDXG Buy 9.35%
2025-01-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.71% 1.82%
ESPR Esperion Therapeutics, Inc. Buy 13.02% -5.98%
AXGN AxoGen, Inc. Buy 14.33% 3.51%
INSM Insmed Incorporated Buy 15.75% 13.81%
ACRS Aclaris Therapeutics, Inc. Buy 14.42% 4%
MD Pediatrix Medical Group, Inc. Buy 2.72% 0.5%
MDXG MiMedx Group, Inc. Buy 2.76% 1.93%
ORGO Organogenesis Holdings Inc. Buy 35.47% 5.11%
NUTX Nutex Health Inc. Buy 9.3% -1.01%
SIGA SIGA Technologies, Inc. Buy 7.88% 0%
TGTX TG Therapeutics, Inc. Sell -5.99% -4.07%
FATE Fate Therapeutics, Inc. Sell -4.35% 23.43%
ORMP Oramed Pharmaceuticals Inc. Sell -5.49% 2.94%
HAE Haemonetics Corporation Sell -7.42% 0.24%
MDRX Allscripts Healthcare Solutions, Inc. Sell -6.12% 5.33%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SIGA
Assets Removed
Asset Action Perf %
BLUE Sell All -20.97%
Assets Rebalanced
None
2025-01-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.2% -17.94%
AORT Artivion, Inc. Buy 12.03% 4.5%
ESPR Esperion Therapeutics, Inc. Buy 12.74% -8.12%
AXGN AxoGen, Inc. Buy 14.41% 3.95%
INSM Insmed Incorporated Buy 15.43% 11.34%
ACRS Aclaris Therapeutics, Inc. Buy 14.44% 4%
MD Pediatrix Medical Group, Inc. Buy 2.71% 0%
MDXG MiMedx Group, Inc. Buy 2.81% 3.63%
ORGO Organogenesis Holdings Inc. Buy 35.82% 6.01%
NUTX Nutex Health Inc. Buy 9.41% 0%
TGTX TG Therapeutics, Inc. Sell -6.15% -6.64%
FATE Fate Therapeutics, Inc. Sell -4.29% 24.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.47% 3.36%
HAE Haemonetics Corporation Sell -7.62% -2.33%
MDRX Allscripts Healthcare Solutions, Inc. Sell -6.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
  • NUTX
Assets Removed
Asset Action Perf %
APLS Buy All -9.8%
TNDM Sell All -5.5%
Assets Rebalanced
None
2025-01-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.49% -16.73%
TNDM Tandem Diabetes Care, Inc. Buy 10.24% 0.47%
AORT Artivion, Inc. Buy 12.14% 3.34%
ESPR Esperion Therapeutics, Inc. Buy 13.67% -3.42%
AXGN AxoGen, Inc. Buy 14.28% 0.99%
INSM Insmed Incorporated Buy 14.92% 5.54%
ACRS Aclaris Therapeutics, Inc. Buy 14.22% 0.4%
MD Pediatrix Medical Group, Inc. Buy 2.72% -1.64%
MDXG MiMedx Group, Inc. Buy 2.85% 2.95%
ORGO Organogenesis Holdings Inc. Buy 34.48% 0%
TGTX TG Therapeutics, Inc. Sell -6.12% -4.07%
FATE Fate Therapeutics, Inc. Sell -4.15% 28.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.63% 2.52%
APLS Apellis Pharmaceuticals, Inc. Sell -6.51% -8.35%
HAE Haemonetics Corporation Sell -7.6% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HAE
  • ORGO
Assets Removed
Asset Action Perf %
NUTX Buy All -22.6%
MDRX Sell All -6.56%
Assets Rebalanced
None
2025-01-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.86% -16.43%
TNDM Tandem Diabetes Care, Inc. Buy 10.21% -3.76%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.85% -4.51%
AORT Artivion, Inc. Buy 12.15% -0.56%
ESPR Esperion Therapeutics, Inc. Buy 13.91% -5.56%
AXGN AxoGen, Inc. Buy 15.1% 2.63%
INSM Insmed Incorporated Buy 14.99% 1.84%
ACRS Aclaris Therapeutics, Inc. Buy 14.8% 0.4%
MD Pediatrix Medical Group, Inc. Buy 2.88% 0%
MDXG MiMedx Group, Inc. Buy 2.88% 0%
TGTX TG Therapeutics, Inc. Sell -6.59% -7.79%
FATE Fate Therapeutics, Inc. Sell -4.56% 24.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.91% 1.68%
NUTX Nutex Health Inc. Sell 15.05% -5.86%
APLS Apellis Pharmaceuticals, Inc. Sell -6.61% -5.79%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
  • MDXG
Assets Removed
Asset Action Perf %
ARDX Sell All 0.19%
Assets Rebalanced
None
2025-01-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.61% -19.25%
TNDM Tandem Diabetes Care, Inc. Buy 10.21% -4.19%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.66% -6.67%
AORT Artivion, Inc. Buy 12.06% -1.82%
ARDX Ardelyx, Inc. Buy 12.93% 5.24%
ESPR Esperion Therapeutics, Inc. Buy 14.17% -4.27%
AXGN AxoGen, Inc. Buy 14.78% -0.05%
INSM Insmed Incorporated Buy 14.65% -0.93%
ACRS Aclaris Therapeutics, Inc. Buy 14.81% 0%
NUTX Nutex Health Inc. Sell 14.81% -3.63%
TGTX TG Therapeutics, Inc. Sell -6.53% -6.21%
FATE Fate Therapeutics, Inc. Sell -4.34% 28.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.99% 0.84%
APLS Apellis Pharmaceuticals, Inc. Sell -6.34% -0.91%
The percentage of cash held in the portfolio is: -4.51%
New Assets Added
  • NUTX
  • ACRS
Assets Removed
None
Assets Rebalanced
None
2025-01-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.1% -3.07%
BLUE bluebird bio, Inc. Buy 8.92% -14.42%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.88% -2.56%
AORT Artivion, Inc. Buy 11.65% -2.94%
ARDX Ardelyx, Inc. Buy 13.22% 10.11%
ESPR Esperion Therapeutics, Inc. Buy 14.09% -2.56%
AXGN AxoGen, Inc. Buy 14.46% 0%
INSM Insmed Incorporated Buy 14.46% 0%
TGTX TG Therapeutics, Inc. Sell -5.94% 1.18%
FATE Fate Therapeutics, Inc. Sell -4.37% 26.29%
ORMP Oramed Pharmaceuticals Inc. Sell -5.86% 0.84%
NUTX Nutex Health Inc. Sell -6.12% 0.39%
APLS Apellis Pharmaceuticals, Inc. Sell -6.4% -4.19%
The percentage of cash held in the portfolio is: 30.91%
New Assets Added
  • AXGN
  • INSM
Assets Removed
None
Assets Rebalanced
None
2025-01-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.25% -3.63%
BLUE bluebird bio, Inc. Buy 9.07% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.11% -2.46%
AORT Artivion, Inc. Buy 12.11% -1.16%
ARDX Ardelyx, Inc. Buy 11.64% -5.06%
ESPR Esperion Therapeutics, Inc. Buy 14.76% 0%
TGTX TG Therapeutics, Inc. Sell -6.33% -3.14%
FATE Fate Therapeutics, Inc. Sell -5.09% 16%
ORMP Oramed Pharmaceuticals Inc. Sell -6.05% -0.42%
NUTX Nutex Health Inc. Sell -6.27% 0%
APLS Apellis Pharmaceuticals, Inc. Sell -6.27% 0%
The percentage of cash held in the portfolio is: 61.06%
New Assets Added
  • NUTX
  • APLS
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2025-01-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.61% 0.36%
BLUE bluebird bio, Inc. Buy 9.02% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.05% -2.46%
AORT Artivion, Inc. Buy 12.19% 0%
ARDX Ardelyx, Inc. Buy 12.19% 0%
TGTX TG Therapeutics, Inc. Sell -6.27% -2.75%
FATE Fate Therapeutics, Inc. Sell -5.75% 4.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.99% 0%
The percentage of cash held in the portfolio is: 62.95%
New Assets Added
  • ORMP
  • AORT
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2025-01-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.42% -0.82%
BLUE bluebird bio, Inc. Buy 9.55% -9.07%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.26% 0%
TGTX TG Therapeutics, Inc. Sell -6.06% 0%
FATE Fate Therapeutics, Inc. Sell -5.98% 0%
The percentage of cash held in the portfolio is: 80.81%
New Assets Added
  • FATE
  • MDRX
Assets Removed
None
Assets Rebalanced
None
2025-01-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.4% 0%
BLUE bluebird bio, Inc. Buy 10.4% 0%
TGTX TG Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 85.2%
New Assets Added
  • TGTX
  • TNDM
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2024-12-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PCRX Sell All NA
Assets Rebalanced
None
2024-12-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 13.2% 1.99%
The percentage of cash held in the portfolio is: 86.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
CUTR Buy All 19.51%
NKTR Buy All 14.95%
FATE Buy All 36.88%
Assets Rebalanced
None
2024-12-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 13% -0.58%
CUTR Cutera, Inc. Sell -5.83% 12.2%
NKTR Nektar Therapeutics Sell -5.77% 13.08%
FATE Fate Therapeutics, Inc. Sell -4.24% 36.12%
The percentage of cash held in the portfolio is: 102.85%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Buy All 48.02%
Assets Rebalanced
None
2024-12-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 13.66% 3.88%
IBRX ImmunityBio, Inc. Sell -3.58% 43.85%
CUTR Cutera, Inc. Sell -5.7% 14.63%
NKTR Nektar Therapeutics Sell -6.37% 4.67%
FATE Fate Therapeutics, Inc. Sell -4.78% 28.52%
The percentage of cash held in the portfolio is: 106.77%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All 5.82%
MGNX Sell All -1.76%
Assets Rebalanced
None
2024-12-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 13.02% 4.2%
MGNX MacroGenics, Inc. Buy 12.53% 0.29%
PCRX Pacira BioSciences, Inc. Buy 14.14% 6.5%
IBRX ImmunityBio, Inc. Sell -4.03% 37.5%
CUTR Cutera, Inc. Sell -5.92% 12.2%
NKTR Nektar Therapeutics Sell -6.43% 4.67%
FATE Fate Therapeutics, Inc. Sell -5.59% 17.11%
The percentage of cash held in the portfolio is: 82.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -13.23%
Assets Rebalanced
None
2024-12-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 13.4% 7.32%
MGNX MacroGenics, Inc. Buy 12.78% 2.35%
ESPR Esperion Therapeutics, Inc. Buy 12.94% 23.55%
PCRX Pacira BioSciences, Inc. Buy 13.27% 0%
IBRX ImmunityBio, Inc. Sell -6.13% 4.76%
CUTR Cutera, Inc. Sell -6.08% 9.76%
NKTR Nektar Therapeutics Sell -6.36% 5.61%
FATE Fate Therapeutics, Inc. Sell -6.97% -3.42%
The percentage of cash held in the portfolio is: 73.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
PACB Buy All -23.86%
RVNC Sell All -27.34%
Assets Rebalanced
None
2024-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.75% 4.6%
MGNX MacroGenics, Inc. Buy 12.51% 2.65%
ESPR Esperion Therapeutics, Inc. Buy 12.07% 18.06%
RVNC Revance Therapeutics, Inc. Buy 12.95% 0%
PCRX Pacira BioSciences, Inc. Buy 12.95% 0%
PACB Pacific Biosciences of California, Inc. Sell -5.45% -18.18%
IBRX ImmunityBio, Inc. Sell -5.91% 5.95%
CUTR Cutera, Inc. Sell -6.9% -4.88%
NKTR Nektar Therapeutics Sell -6.27% 4.67%
FATE Fate Therapeutics, Inc. Sell -6.4% 2.66%
The percentage of cash held in the portfolio is: 67.7%
New Assets Added
  • RVNC
  • PCRX
Assets Removed
Asset Action Perf %
ARWR Sell All -11.63%
Assets Rebalanced
None
2024-12-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.84% 6.13%
MGNX MacroGenics, Inc. Buy 12.24% 1.18%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.77% -0.31%
ESPR Esperion Therapeutics, Inc. Buy 10.64% 4.84%
PACB Pacific Biosciences of California, Inc. Sell -4.76% -3.98%
IBRX ImmunityBio, Inc. Sell -5.65% 9.52%
CUTR Cutera, Inc. Sell -6.53% 0%
NKTR Nektar Therapeutics Sell -6.53% 0%
FATE Fate Therapeutics, Inc. Sell -6.53% 0%
The percentage of cash held in the portfolio is: 82.5%
New Assets Added
  • CUTR
  • NKTR
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 13.13% 8.55%
MGNX MacroGenics, Inc. Buy 13.13% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.89% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 10.15% 0%
PACB Pacific Biosciences of California, Inc. Sell -5.01% -9.66%
IBRX ImmunityBio, Inc. Sell -6.15% 1.39%
The percentage of cash held in the portfolio is: 62.87%
New Assets Added
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-12-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.62% 3.98%
MGNX MacroGenics, Inc. Buy 12.81% 5.59%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.78% -0.46%
FATE Fate Therapeutics, Inc. Buy 11.84% 0%
PACB Pacific Biosciences of California, Inc. Sell -4.98% -8.52%
IBRX ImmunityBio, Inc. Sell -6.26% 0%
The percentage of cash held in the portfolio is: 62.19%
New Assets Added
  • IBRX
Assets Removed
Asset Action Perf %
CUTR Buy All -25.64%
Assets Rebalanced
None
2024-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.54% 4.63%
MGNX MacroGenics, Inc. Buy 12.83% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.69% 0%
FATE Fate Therapeutics, Inc. Buy 11.69% 0%
CUTR Cutera, Inc. Sell -7.65% -17.95%
PACB Pacific Biosciences of California, Inc. Sell -4.53% 0%
The percentage of cash held in the portfolio is: 63.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMPH Buy All NA
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.54% 4.63%
MGNX MacroGenics, Inc. Buy 12.83% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.69% 0%
FATE Fate Therapeutics, Inc. Buy 11.69% 0%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.75% 1.91%
CUTR Cutera, Inc. Sell -7.65% -17.95%
PACB Pacific Biosciences of California, Inc. Sell -4.53% 0%
The percentage of cash held in the portfolio is: 72.17%
New Assets Added
  • PACB
  • ARWR
  • FATE
Assets Removed
Asset Action Perf %
AZTA Buy All -10.51%
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 11.97% 0%
MGNX MacroGenics, Inc. Buy 11.97% 0%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.55% 4.06%
CUTR Cutera, Inc. Sell -6.48% 0%
AZTA Azenta, Inc. Sell -6.67% -7.34%
The percentage of cash held in the portfolio is: 97.76%
New Assets Added
  • APLS
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.55% 3.15%
CUTR Cutera, Inc. Sell -5.43% 15.38%
AZTA Azenta, Inc. Sell -6.59% -6.92%
The percentage of cash held in the portfolio is: 120.56%
New Assets Added
None
Assets Removed
Asset Action Perf %
CORT Sell All 17.92%
Assets Rebalanced
None
2024-11-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
CORT Corcept Therapeutics Incorporated Buy 12.83% 12.05%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.44% 4.34%
CUTR Cutera, Inc. Sell -4.93% 23.08%
AZTA Azenta, Inc. Sell -6.45% -4.74%
The percentage of cash held in the portfolio is: 106.99%
New Assets Added
None
Assets Removed
Asset Action Perf %
IRTC Sell All -9.45%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CORT Corcept Therapeutics Incorporated Buy 12.37% 8.49%
IRTC iRhythm Technologies, Inc. Buy 10.56% -7.33%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.31% 5.36%
CUTR Cutera, Inc. Sell -4.91% 23.08%
AZTA Azenta, Inc. Sell -5.88% 4.03%
The percentage of cash held in the portfolio is: 96.17%
New Assets Added
None
Assets Removed
Asset Action Perf %
NEOG Sell All 5.23%
MGNX Sell All -10.08%
Assets Rebalanced
None
2024-11-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 12.04% 6%
MGNX MacroGenics, Inc. Buy 9.96% -9.3%
CORT Corcept Therapeutics Incorporated Buy 11.97% 5.11%
IRTC iRhythm Technologies, Inc. Buy 10.75% -5.62%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.4% 4.19%
CUTR Cutera, Inc. Sell -4.74% 25.64%
AZTA Azenta, Inc. Sell -5.8% 5.3%
The percentage of cash held in the portfolio is: 74.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Buy All -8.17%
VERU Buy All 29.76%
HCSG Sell All 2.56%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.6% 5.39%
NEOG Neogen Corporation Buy 11.56% 1.81%
MGNX MacroGenics, Inc. Buy 10.13% -7.75%
CORT Corcept Therapeutics Incorporated Buy 11.78% 3.54%
IRTC iRhythm Technologies, Inc. Buy 11.24% -1.22%
CHRS Coherus BioSciences, Inc. Sell -6.12% -3.05%
VERU Veru Inc. Sell -4.1% 30.95%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.48% 3.21%
CUTR Cutera, Inc. Sell -5.23% 17.95%
AZTA Azenta, Inc. Sell -5.96% 2.63%
The percentage of cash held in the portfolio is: 70.58%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.66% 8.95%
NEOG Neogen Corporation Buy 11.26% 2.09%
MGNX MacroGenics, Inc. Buy 10.49% -1.55%
CORT Corcept Therapeutics Incorporated Buy 12.09% 9.45%
IRTC iRhythm Technologies, Inc. Buy 11.32% 2.46%
RGEN Repligen Corporation Buy 13.2% -5.34%
CHRS Coherus BioSciences, Inc. Sell -6.18% -7.06%
VERU Veru Inc. Sell -4.33% 25%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.32% 2.23%
CUTR Cutera, Inc. Sell -5.24% 15.38%
AZTA Azenta, Inc. Sell -5.94% 0%
The percentage of cash held in the portfolio is: 56.97%
New Assets Added
  • AZTA
Assets Removed
Asset Action Perf %
COLL Buy All 11.77%
SAGE Sell All -15.03%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 14.38% 11.32%
NEOG Neogen Corporation Buy 11.21% 5.86%
MGNX MacroGenics, Inc. Buy 9.97% -2.58%
CORT Corcept Therapeutics Incorporated Buy 11.96% 12.76%
IRTC iRhythm Technologies, Inc. Buy 11.35% 6.99%
SAGE Sage Therapeutics, Inc. Buy 13.63% -9.34%
ALT Altimmune, Inc. Buy 13.26% 0.32%
RGEN Repligen Corporation Buy 13.39% 0%
COLL Collegium Pharmaceutical, Inc. Sell -4.32% 12.04%
CHRS Coherus BioSciences, Inc. Sell -5.98% -7.89%
VERU Veru Inc. Sell -4.09% 26.19%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.06% 1.32%
CUTR Cutera, Inc. Sell -5.48% 7.69%
The percentage of cash held in the portfolio is: 28.77%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
CARA Sell All -6.09%
CDMO Sell All 17.76%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 12.76% 18.05%
HCSG Healthcare Services Group, Inc. Buy 14.58% 13.61%
NEOG Neogen Corporation Buy 11.25% 6.97%
MGNX MacroGenics, Inc. Buy 10.77% 5.94%
CORT Corcept Therapeutics Incorporated Buy 12.17% 15.44%
IRTC iRhythm Technologies, Inc. Buy 11.28% 7.07%
CARA Cara Therapeutics, Inc. Buy 14.76% -1.16%
SAGE Sage Therapeutics, Inc. Buy 13.54% -9.34%
ALT Altimmune, Inc. Buy 13.13% 0%
COLL Collegium Pharmaceutical, Inc. Sell -4.46% 8.45%
CHRS Coherus BioSciences, Inc. Sell -6.28% -14.13%
VERU Veru Inc. Sell -4.32% 21.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.4% -3.51%
CUTR Cutera, Inc. Sell -5.9% 0%
The percentage of cash held in the portfolio is: 15.13%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
IOVA Sell All -12.15%
NUTX Sell All 51.33%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 13.88% 27.16%
CDMO Avid Bioservices, Inc. Buy 12.8% 18.34%
HCSG Healthcare Services Group, Inc. Buy 13.93% 8.4%
IOVA Iovance Biotherapeutics, Inc. Buy 10% -3.99%
NEOG Neogen Corporation Buy 11.91% 13.18%
MGNX MacroGenics, Inc. Buy 11.44% 12.4%
CORT Corcept Therapeutics Incorporated Buy 12.56% 19.06%
IRTC iRhythm Technologies, Inc. Buy 11.2% 6.19%
CARA Cara Therapeutics, Inc. Buy 14.73% -1.45%
SAGE Sage Therapeutics, Inc. Buy 14.93% -0.16%
COLL Collegium Pharmaceutical, Inc. Sell -4.57% 6.27%
CHRS Coherus BioSciences, Inc. Sell -6.22% -12.88%
VERU Veru Inc. Sell -4.79% 13.1%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.52% -4.82%
CUTR Cutera, Inc. Sell -5.91% 0%
The percentage of cash held in the portfolio is: 2.61%
New Assets Added
  • CUTR
Assets Removed
Asset Action Perf %
EVH Buy All 42.39%
Assets Rebalanced
Asset Action Weight
HCSG Buy 1.34%
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 13.06% 16.4%
CDMO Avid Bioservices, Inc. Buy 13.13% 18.15%
HCSG Healthcare Services Group, Inc. Buy 11.65% 7.31%
IOVA Iovance Biotherapeutics, Inc. Buy 11.92% 11.33%
NEOG Neogen Corporation Buy 11.9% 10.04%
MGNX MacroGenics, Inc. Buy 12.05% 15.25%
IRTC iRhythm Technologies, Inc. Buy 11.81% 8.99%
CORT Corcept Therapeutics Incorporated Buy 11.76% 8.47%
CARA Cara Therapeutics, Inc. Buy 15.36% 0%
SAGE Sage Therapeutics, Inc. Buy 15.36% 0%
EVH Evolent Health, Inc. Sell -5.24% -5.95%
COLL Collegium Pharmaceutical, Inc. Sell -5.07% -1.17%
CHRS Coherus BioSciences, Inc. Sell -6.43% -13.57%
VERU Veru Inc. Sell -4.92% 13.1%
AMPH Amphastar Pharmaceuticals, Inc. Sell -8.35% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMPH
  • CARA
  • SAGE
Assets Removed
Asset Action Perf %
NVRO Sell All -1.11%
VREX Sell All 17.93%
Assets Rebalanced
None
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 11.92% 19.42%
NUTX Nutex Health Inc. Buy 12.43% 9.47%
CDMO Avid Bioservices, Inc. Buy 11.92% 5.98%
HCSG Healthcare Services Group, Inc. Buy 11.92% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 11.92% 10.06%
NEOG Neogen Corporation Buy 11.92% 8.93%
NVRO Nevro Corp. Buy 11.79% 7.04%
MGNX MacroGenics, Inc. Buy 11.46% 8.27%
IRTC iRhythm Technologies, Inc. Buy 12.06% 9.9%
CORT Corcept Therapeutics Incorporated Buy 11.88% 8.33%
EVH Evolent Health, Inc. Sell -5.34% -6.81%
COLL Collegium Pharmaceutical, Inc. Sell -5.1% -0.55%
CHRS Coherus BioSciences, Inc. Sell -5.74% -0.28%
VERU Veru Inc. Sell -5.05% 11.9%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All -11.47%
Assets Rebalanced
Asset Action Weight
NVRO Sell -1.25%
HCSG Sell -11.43%
IOVA Sell -11.76%
NUTX Buy 1.07%
VREX Buy 2.76%
NEOG Buy 4.72%
CDMO Buy 9.55%
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.21% 9.5%
NUTX Nutex Health Inc. Buy 10.1% -7.17%
CDMO Avid Bioservices, Inc. Buy 2.45% -0.19%
HCSG Healthcare Services Group, Inc. Buy 24.08% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 24.48% 3.72%
NEOG Neogen Corporation Buy 7.3% 0.63%
NVRO Nevro Corp. Buy 13.24% -0.93%
MGNX MacroGenics, Inc. Buy 11.1% -4.39%
IRTC iRhythm Technologies, Inc. Buy 12.03% 0%
CORT Corcept Therapeutics Incorporated Buy 12.03% 0%
EVH Evolent Health, Inc. Sell -5.53% -0.73%
SMTI Sanara MedTech Inc. Sell -5.9% -6.02%
COLL Collegium Pharmaceutical, Inc. Sell -5.31% 4.63%
CHRS Coherus BioSciences, Inc. Sell -5.83% 7.2%
VERU Veru Inc. Sell -5.46% 13.1%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IRTC
  • CORT
Assets Removed
Asset Action Perf %
ARWR Sell All 3.62%
VCEL Sell All 5.42%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.74% 0.67%
VCEL Vericel Corporation Buy 12.18% 4.51%
VREX Varex Imaging Corporation Buy 9.28% 9.09%
NUTX Nutex Health Inc. Buy 10.02% -8.94%
CDMO Avid Bioservices, Inc. Buy 2.46% -0.87%
HCSG Healthcare Services Group, Inc. Buy 24.31% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 24.23% 1.45%
NEOG Neogen Corporation Buy 7.39% 0.7%
NVRO Nevro Corp. Buy 13.84% 2.41%
MGNX MacroGenics, Inc. Buy 11.74% 0%
EVH Evolent Health, Inc. Sell -5.61% -1.16%
SMTI Sanara MedTech Inc. Sell -5.98% -6.21%
COLL Collegium Pharmaceutical, Inc. Sell -5.49% 2.48%
CHRS Coherus BioSciences, Inc. Sell -6.36% -0.14%
VERU Veru Inc. Sell -5.75% 9.52%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
ARDX Sell All 0.83%
Assets Rebalanced
None
2024-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 11.45% -2.48%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.95% 1.81%
VCEL Vericel Corporation Buy 12.7% 8.2%
VREX Varex Imaging Corporation Buy 9.45% 10.33%
NUTX Nutex Health Inc. Buy 10.51% -5.16%
CDMO Avid Bioservices, Inc. Buy 2.45% -2.03%
HCSG Healthcare Services Group, Inc. Buy 24.26% 0.91%
IOVA Iovance Biotherapeutics, Inc. Buy 24.06% 0.09%
NEOG Neogen Corporation Buy 7.51% 1.6%
NVRO Nevro Corp. Buy 13.61% 0%
EVH Evolent Health, Inc. Sell -5.82% -4.1%
SMTI Sanara MedTech Inc. Sell -5.88% -3.8%
COLL Collegium Pharmaceutical, Inc. Sell -5.73% -1.05%
CHRS Coherus BioSciences, Inc. Sell -6.65% -3.88%
VERU Veru Inc. Sell -5.86% 8.33%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVRO
Assets Removed
Asset Action Perf %
ALGN Sell All -2.57%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 11.77% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.2% 3.2%
VCEL Vericel Corporation Buy 12.87% 8.89%
VREX Varex Imaging Corporation Buy 9.49% 10%
NUTX Nutex Health Inc. Buy 9.94% -10.96%
CDMO Avid Bioservices, Inc. Buy 2.48% -1.74%
ALGN Align Technology, Inc. Buy 13.7% -1.68%
HCSG Healthcare Services Group, Inc. Buy 24.37% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 23.74% -1.99%
NEOG Neogen Corporation Buy 7.44% 0%
EVH Evolent Health, Inc. Sell -5.65% -0.34%
SMTI Sanara MedTech Inc. Sell -5.86% -2.69%
COLL Collegium Pharmaceutical, Inc. Sell -5.86% -2.71%
CHRS Coherus BioSciences, Inc. Sell -6.63% -2.91%
VERU Veru Inc. Sell -6.14% 4.76%
The percentage of cash held in the portfolio is: 2.14%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 11.39% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.16% 4.24%
VCEL Vericel Corporation Buy 12.65% 8.48%
VREX Varex Imaging Corporation Buy 9.25% 8.68%
NKTR Nektar Therapeutics Buy 7.99% -6.21%
NUTX Nutex Health Inc. Buy 10.64% -3.3%
CDMO Avid Bioservices, Inc. Buy 2.42% -2.51%
ALGN Align Technology, Inc. Buy 13.71% -0.29%
HCSG Healthcare Services Group, Inc. Buy 23.89% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 23.89% 0%
EVH Evolent Health, Inc. Sell -5.65% -1.81%
SMTI Sanara MedTech Inc. Sell -5.87% -4.15%
COLL Collegium Pharmaceutical, Inc. Sell -5.77% -2.39%
CHRS Coherus BioSciences, Inc. Sell -6.36% 0%
VERU Veru Inc. Sell -6.36% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CHRS
  • VERU
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 12.01% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.05% 3.82%
VCEL Vericel Corporation Buy 13.07% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 19.43% 54.64%
VREX Varex Imaging Corporation Buy 9.79% 6.69%
NKTR Nektar Therapeutics Buy 8.35% -8.97%
NUTX Nutex Health Inc. Buy 11.61% -2.14%
CDMO Avid Bioservices, Inc. Buy 2.59% -3.47%
ALGN Align Technology, Inc. Buy 15.01% 1.33%
EVH Evolent Health, Inc. Sell -6.2% -3.58%
SMTI Sanara MedTech Inc. Sell -6.1% -0.48%
COLL Collegium Pharmaceutical, Inc. Sell -6.14% -1.14%
The percentage of cash held in the portfolio is: 13.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.74% -6.82%
ARDX Ardelyx, Inc. Buy 12.14% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.87% 2.94%
VCEL Vericel Corporation Buy 12.74% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 19.2% 53.61%
VREX Varex Imaging Corporation Buy 9.67% 5.95%
NKTR Nektar Therapeutics Buy 8.5% -6.9%
NUTX Nutex Health Inc. Buy 11.69% -0.97%
CDMO Avid Bioservices, Inc. Buy 2.63% -1.45%
ALGN Align Technology, Inc. Buy 14.74% 0%
EVH Evolent Health, Inc. Sell -5.85% 1.81%
SMTI Sanara MedTech Inc. Sell -6.04% 0%
COLL Collegium Pharmaceutical, Inc. Sell -6.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • COLL
  • ALGN
Assets Removed
None
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.83% -6.17%
ARDX Ardelyx, Inc. Buy 11.56% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.87% 2.89%
VCEL Vericel Corporation Buy 12.57% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 19.85% 58.76%
VREX Varex Imaging Corporation Buy 9.62% 5.37%
NKTR Nektar Therapeutics Buy 8.88% -2.76%
NUTX Nutex Health Inc. Buy 11.23% -4.88%
CDMO Avid Bioservices, Inc. Buy 2.67% 0%
EVH Evolent Health, Inc. Sell -5.75% 3.41%
The percentage of cash held in the portfolio is: 4.67%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CUTR Buy All 12%
FATE Buy All 5.61%
ORMP Buy All 0.42%
IRWD Sell All -6.57%
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.01% -4.23%
ORGO Organogenesis Holdings Inc. Buy 12.92% 0.65%
ARDX Ardelyx, Inc. Buy 12.19% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.41% 5.27%
VCEL Vericel Corporation Buy 12.66% -0.62%
CDXS Codexis, Inc. Buy 12.39% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 15.88% 24.74%
VREX Varex Imaging Corporation Buy 9.64% 3.64%
NKTR Nektar Therapeutics Buy 9.23% -0.69%
NUTX Nutex Health Inc. Buy 12.02% 0%
CUTR Cutera, Inc. Sell -5.54% 6.8%
FATE Fate Therapeutics, Inc. Sell -5.91% 0.62%
ORMP Oramed Pharmaceuticals Inc. Sell -5.9% 0.84%
EVH Evolent Health, Inc. Sell -6% 0.99%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
Assets Removed
Asset Action Perf %
IRTC Buy All -20.54%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.6% -1.64%
ORGO Organogenesis Holdings Inc. Buy 13.29% 0.97%
ARDX Ardelyx, Inc. Buy 12.72% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.82% 5.84%
VCEL Vericel Corporation Buy 12.78% -2.16%
CDXS Codexis, Inc. Buy 12.67% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 12.25% -6.19%
VREX Varex Imaging Corporation Buy 9.93% 4.13%
NKTR Nektar Therapeutics Buy 9.14% -4.14%
CUTR Cutera, Inc. Sell -5.69% 6.67%
FATE Fate Therapeutics, Inc. Sell -5.98% 1.87%
ORMP Oramed Pharmaceuticals Inc. Sell -6% 1.67%
IRTC iRhythm Technologies, Inc. Sell -6.11% 0.97%
EVH Evolent Health, Inc. Sell -6.22% 0%
The percentage of cash held in the portfolio is: 21.81%
New Assets Added
  • EVH
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.05% 4.23%
ORGO Organogenesis Holdings Inc. Buy 12.87% -0.32%
ARDX Ardelyx, Inc. Buy 12.37% -3.48%
BKD Brookdale Senior Living Inc. Buy 14% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.79% 7.64%
VCEL Vericel Corporation Buy 12.38% -3.37%
CDXS Codexis, Inc. Buy 12.73% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 12.41% -3.09%
VREX Varex Imaging Corporation Buy 9.35% 0%
NKTR Nektar Therapeutics Buy 9.35% 0%
CUTR Cutera, Inc. Sell -5.26% 12%
FATE Fate Therapeutics, Inc. Sell -6% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -6.01% -0.42%
IRTC iRhythm Technologies, Inc. Sell -6.03% 0.35%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VREX
  • NKTR
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.78% 3.05%
ORGO Organogenesis Holdings Inc. Buy 13.26% 3.9%
ARDX Ardelyx, Inc. Buy 12.52% -1.16%
BKD Brookdale Senior Living Inc. Buy 12.71% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.01% 2.69%
VCEL Vericel Corporation Buy 12.63% -0.33%
RDNT RadNet, Inc. Buy 12.69% 0.2%
CDXS Codexis, Inc. Buy 12.66% 0%
SGMO Sangamo Therapeutics, Inc. Buy 12.66% 0%
CUTR Cutera, Inc. Sell -5.44% 8%
FATE Fate Therapeutics, Inc. Sell -5.62% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -5.82% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.74% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -5.97% 0.18%
The percentage of cash held in the portfolio is: 14.66%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.63% 0.7%
ORGO Organogenesis Holdings Inc. Buy 12.94% 0.32%
ARDX Ardelyx, Inc. Buy 12.69% -0.83%
BKD Brookdale Senior Living Inc. Buy 12.8% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.8% 0%
VCEL Vericel Corporation Buy 12.8% 0%
RDNT RadNet, Inc. Buy 12.8% 0%
CUTR Cutera, Inc. Sell -5.66% 5.33%
FATE Fate Therapeutics, Inc. Sell -5.68% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -5.95% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.58% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -5.96% 1.35%
The percentage of cash held in the portfolio is: 40.39%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.62% 0%
ORGO Organogenesis Holdings Inc. Buy 12.93% -0.32%
ARDX Ardelyx, Inc. Buy 12.87% 0%
CUTR Cutera, Inc. Sell -6.09% -1.33%
FATE Fate Therapeutics, Inc. Sell -5.79% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -5.99% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.53% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -6.15% -1.12%
The percentage of cash held in the portfolio is: 92.12%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.44% -1.17%
ORGO Organogenesis Holdings Inc. Buy 12.67% -1.95%
CUTR Cutera, Inc. Sell -5.83% 2.67%
FATE Fate Therapeutics, Inc. Sell -5.48% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -6.01% -0.42%
IRTC iRhythm Technologies, Inc. Sell -5.54% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -5.81% 4.05%
The percentage of cash held in the portfolio is: 104.57%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.69% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.92% 0%
ORGO Organogenesis Holdings Inc. Buy 12.92% 0%
CUTR Cutera, Inc. Sell -5.99% 0%
FATE Fate Therapeutics, Inc. Sell -6.01% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -5.89% 1.67%
IRTC iRhythm Technologies, Inc. Sell -6.06% 0%
AXSM Axsome Therapeutics, Inc. Sell -6.06% 0%
The percentage of cash held in the portfolio is: 92.47%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.6% 0%
CUTR Cutera, Inc. Sell -6% 0%
FATE Fate Therapeutics, Inc. Sell -6% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 106.4%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 0.6%
CERS Buy All 16.11%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 18.96% -8.98%
VREX Varex Imaging Corporation Sell -5.63% 5.21%
CERS Cerus Corporation Sell -5.06% 14.69%
The percentage of cash held in the portfolio is: 91.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 19.09% -8.42%
MYGN Myriad Genetics, Inc. Buy 9.04% -0.15%
VREX Varex Imaging Corporation Sell -5.99% -0.77%
CERS Cerus Corporation Sell -5.01% 15.64%
The percentage of cash held in the portfolio is: 82.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -10.93%
Assets Rebalanced
None
2024-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 4.92% -4.92%
NVCR NovoCure Limited Buy 19.85% -2.44%
MYGN Myriad Genetics, Inc. Buy 9.33% 5.56%
VREX Varex Imaging Corporation Sell -5.46% 5.73%
CERS Cerus Corporation Sell -4.89% 15.64%
The percentage of cash held in the portfolio is: 76.26%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Buy All 6.46%
PODD Sell All 15.5%
Assets Rebalanced
None
2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 24.76% 15.22%
ESPR Esperion Therapeutics, Inc. Buy 5.03% -2.73%
NVCR NovoCure Limited Buy 20.3% -0.17%
MYGN Myriad Genetics, Inc. Buy 9.37% 6.04%
AVXL Anavex Life Sciences Corp. Sell -5.54% 7.14%
VREX Varex Imaging Corporation Sell -5.5% 5.04%
CERS Cerus Corporation Sell -5.41% 6.64%
The percentage of cash held in the portfolio is: 56.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 0.59%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 24.86% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 5.03% -3.83%
NVCR NovoCure Limited Buy 20.45% -0.5%
MYGN Myriad Genetics, Inc. Buy 9.24% 3.45%
STAA STAAR Surgical Company Sell -6.11% 3.06%
AVXL Anavex Life Sciences Corp. Sell -5.84% 3.06%
VREX Varex Imaging Corporation Sell -5.77% 1.45%
CERS Cerus Corporation Sell -5.72% 2.37%
The percentage of cash held in the portfolio is: 63.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 7.43%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 11.78% 2.86%
PODD Insulet Corporation Buy 24.83% 14.41%
TVTX Travere Therapeutics, Inc. Buy 7.34% 40.42%
ESPR Esperion Therapeutics, Inc. Buy 5.46% 4.37%
NVCR NovoCure Limited Buy 21.13% 2.88%
MYGN Myriad Genetics, Inc. Buy 9.12% 2.3%
STAA STAAR Surgical Company Sell -6.29% -0.03%
AVXL Anavex Life Sciences Corp. Sell -5.44% 9.69%
VREX Varex Imaging Corporation Sell -5.91% -1.03%
CERS Cerus Corporation Sell -5.74% 1.9%
The percentage of cash held in the portfolio is: 43.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All -5.48%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 11.88% 1.14%
PODD Insulet Corporation Buy 25.09% 12.73%
TVTX Travere Therapeutics, Inc. Buy 7.04% 31.25%
ESPR Esperion Therapeutics, Inc. Buy 5.13% -4.37%
NVCR NovoCure Limited Buy 20.22% -3.99%
MYGN Myriad Genetics, Inc. Buy 8.95% -2.15%
CDMO Avid Bioservices, Inc. Sell -6.83% -5.48%
STAA STAAR Surgical Company Sell -5.97% 7.41%
AVXL Anavex Life Sciences Corp. Sell -5.47% 11.39%
VREX Varex Imaging Corporation Sell -5.89% 1.88%
CERS Cerus Corporation Sell -5.8% 3.32%
The percentage of cash held in the portfolio is: 51.67%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 8.41%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 10.83% 3.11%
AADI Aadi Bioscience, Inc. Buy 12.4% 5.14%
PODD Insulet Corporation Buy 24.9% 11.4%
TVTX Travere Therapeutics, Inc. Buy 6.86% 27.5%
ESPR Esperion Therapeutics, Inc. Buy 5.12% -4.92%
NVCR NovoCure Limited Buy 20.18% -4.54%
MYGN Myriad Genetics, Inc. Buy 8.95% -2.56%
CDMO Avid Bioservices, Inc. Sell -6.51% -0.19%
STAA STAAR Surgical Company Sell -6.07% 6.36%
AVXL Anavex Life Sciences Corp. Sell -5.41% 12.76%
VREX Varex Imaging Corporation Sell -5.89% 2.22%
CERS Cerus Corporation Sell -5.85% 2.84%
The percentage of cash held in the portfolio is: 40.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -3.75%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.35% -1.69%
AGEN Agenus Inc. Buy 10.51% -0.18%
AADI Aadi Bioscience, Inc. Buy 12.02% 1.71%
PODD Insulet Corporation Buy 24.81% 10.8%
TVTX Travere Therapeutics, Inc. Buy 7.21% 33.75%
ESPR Esperion Therapeutics, Inc. Buy 5.1% -5.46%
NVCR NovoCure Limited Buy 19.84% -6.37%
MYGN Myriad Genetics, Inc. Buy 9.23% 0.26%
CDMO Avid Bioservices, Inc. Sell -6.46% 0.85%
STAA STAAR Surgical Company Sell -6.05% 6.89%
AVXL Anavex Life Sciences Corp. Sell -5.29% 14.88%
VREX Varex Imaging Corporation Sell -5.86% 2.99%
CERS Cerus Corporation Sell -5.87% 2.84%
The percentage of cash held in the portfolio is: 30.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.45% 0.21%
CARA Cara Therapeutics, Inc. Buy 9.43% -9.62%
AGEN Agenus Inc. Buy 9.78% -6.22%
AADI Aadi Bioscience, Inc. Buy 12.11% 3.43%
PODD Insulet Corporation Buy 23.78% 7.2%
TVTX Travere Therapeutics, Inc. Buy 7.16% 33.96%
ESPR Esperion Therapeutics, Inc. Buy 4.96% -7.1%
NVCR NovoCure Limited Buy 19.32% -7.98%
MYGN Myriad Genetics, Inc. Buy 9.17% 0.63%
CDMO Avid Bioservices, Inc. Sell -5.46% 15.41%
STAA STAAR Surgical Company Sell -5.97% 7.17%
AVXL Anavex Life Sciences Corp. Sell -5.39% 12.41%
VREX Varex Imaging Corporation Sell -5.23% 12.56%
CERS Cerus Corporation Sell -5.73% 4.27%
The percentage of cash held in the portfolio is: 21.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.85% 3%
CARA Cara Therapeutics, Inc. Buy 9.89% -6.12%
AGEN Agenus Inc. Buy 9.54% -9.51%
AADI Aadi Bioscience, Inc. Buy 12.37% 4.57%
PODD Insulet Corporation Buy 23.55% 5.05%
TVTX Travere Therapeutics, Inc. Buy 6.18% 14.37%
ESPR Esperion Therapeutics, Inc. Buy 4.87% -9.84%
ALDX Aldeyra Therapeutics, Inc. Buy 20.59% -3.01%
NVCR NovoCure Limited Buy 19.84% -6.48%
MYGN Myriad Genetics, Inc. Buy 9.21% 0%
CDMO Avid Bioservices, Inc. Sell -5.44% 16.54%
STAA STAAR Surgical Company Sell -6.25% 3.86%
AVXL Anavex Life Sciences Corp. Sell -5.45% 12.41%
VREX Varex Imaging Corporation Sell -5.97% 1.28%
CERS Cerus Corporation Sell -5.79% 4.27%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.3% -1.42%
ORGO Organogenesis Holdings Inc. Buy 9.75% -6.71%
CARA Cara Therapeutics, Inc. Buy 9.78% -6.41%
AGEN Agenus Inc. Buy 9.55% -8.59%
AADI Aadi Bioscience, Inc. Buy 12.06% 2.86%
PODD Insulet Corporation Buy 23.5% 5.72%
TVTX Travere Therapeutics, Inc. Buy 5.54% 3.44%
ESPR Esperion Therapeutics, Inc. Buy 5.03% -6.01%
ALDX Aldeyra Therapeutics, Inc. Buy 21.04% 0%
NVCR NovoCure Limited Buy 21.03% 0%
CDMO Avid Bioservices, Inc. Sell -5.5% 14.93%
STAA STAAR Surgical Company Sell -6.21% 3.61%
AVXL Anavex Life Sciences Corp. Sell -5.83% 5.44%
VREX Varex Imaging Corporation Sell -6.13% -2.31%
CERS Cerus Corporation Sell -5.91% 1.42%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.97% -5.21%
ORGO Organogenesis Holdings Inc. Buy 10.03% -4.59%
CARA Cara Therapeutics, Inc. Buy 9.88% -6.12%
AGEN Agenus Inc. Buy 9.33% -11.33%
AADI Aadi Bioscience, Inc. Buy 12.15% 2.86%
PODD Insulet Corporation Buy 23.27% 3.96%
TVTX Travere Therapeutics, Inc. Buy 5.64% 4.69%
ESPR Esperion Therapeutics, Inc. Buy 5.36% -0.55%
ALDX Aldeyra Therapeutics, Inc. Buy 21.19% 0%
CDMO Avid Bioservices, Inc. Sell -5.69% 12.67%
STAA STAAR Surgical Company Sell -6.31% 2.72%
AVXL Anavex Life Sciences Corp. Sell -5.93% 4.42%
VREX Varex Imaging Corporation Sell -6.03% 0%
CERS Cerus Corporation Sell -6.03% 0%
The percentage of cash held in the portfolio is: 23.19%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.25% -2.65%
ORGO Organogenesis Holdings Inc. Buy 10.16% -3.53%
CARA Cara Therapeutics, Inc. Buy 10.16% -3.5%
AGEN Agenus Inc. Buy 9.53% -9.51%
CERS Cerus Corporation Buy 10.88% -7.98%
AADI Aadi Bioscience, Inc. Buy 11.75% -0.57%
PODD Insulet Corporation Buy 22.65% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 20.08% -10.38%
TVTX Travere Therapeutics, Inc. Buy 5.4% 0%
ESPR Esperion Therapeutics, Inc. Buy 5.4% 0%
CDMO Avid Bioservices, Inc. Sell -5.99% 8.03%
STAA STAAR Surgical Company Sell -6.49% 0.15%
AVXL Anavex Life Sciences Corp. Sell -5.77% 7.14%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TVTX
  • ESPR
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.64% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 9.56% -4.2%
ORGO Organogenesis Holdings Inc. Buy 10.33% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.36% 3.79%
AGEN Agenus Inc. Buy 9.33% -6.58%
CERS Cerus Corporation Buy 10.55% -5.88%
AADI Aadi Bioscience, Inc. Buy 10.76% -4%
NEOG Neogen Corporation Buy 15% -2.15%
PODD Insulet Corporation Buy 21.24% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 21.24% 0%
CDMO Avid Bioservices, Inc. Sell -5.97% 3.4%
STAA STAAR Surgical Company Sell -6.07% 1.42%
PINC Premier, Inc. Sell -6.18% -0.3%
AVXL Anavex Life Sciences Corp. Sell -5.89% 0%
VERU Veru Inc. Sell -5.89% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AVXL
  • VERU
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.54% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.71% -0.64%
ORGO Organogenesis Holdings Inc. Buy 10.15% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.23% 4.66%
AGEN Agenus Inc. Buy 10.06% 2.93%
CERS Cerus Corporation Buy 10.7% -2.52%
AADI Aadi Bioscience, Inc. Buy 10.53% -4%
NEOG Neogen Corporation Buy 15% 0%
CDMO Avid Bioservices, Inc. Sell -5.88% 2.74%
STAA STAAR Surgical Company Sell -6.03% 0%
PINC Premier, Inc. Sell -6.03% 0%
The percentage of cash held in the portfolio is: 32.01%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.5% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.58% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.27% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.35% 7.87%
AGEN Agenus Inc. Buy 10.29% 7.31%
CERS Cerus Corporation Buy 10.77% 0%
AADI Aadi Bioscience, Inc. Buy 10.77% 0%
CDMO Avid Bioservices, Inc. Sell -5.81% 2.08%
The percentage of cash held in the portfolio is: 34.3%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.66% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 9.75% 0.64%
ORGO Organogenesis Holdings Inc. Buy 10.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 9.84% 1.46%
AGEN Agenus Inc. Buy 10.28% 6.03%
CDMO Avid Bioservices, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 56.43%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.4% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 9.72% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.61% -2.83%
CARA Cara Therapeutics, Inc. Buy 9.9% 0%
AGEN Agenus Inc. Buy 9.9% 0%
The percentage of cash held in the portfolio is: 51.48%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.8% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 9.8% 0%
ORGO Organogenesis Holdings Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 70.6%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-21 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
EGRX Buy All 3.38%
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Sell -5.84% 4.43%
The percentage of cash held in the portfolio is: 105.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All -1.57%
Assets Rebalanced
None
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.02% -2.95%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.34% 12.45%
The percentage of cash held in the portfolio is: 92.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Buy All -2.48%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 12.44% -7.66%
PODD Insulet Corporation Sell -6.37% 2.34%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.49% 10.34%
The percentage of cash held in the portfolio is: 99.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
RCM Sell All 7.14%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 11.55% 7.06%
CYH Community Health Systems, Inc. Buy 12.7% -5.3%
RMD ResMed Inc. Buy 14.98% 3.67%
PODD Insulet Corporation Sell -6.35% 2.25%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.61% 8.02%
The percentage of cash held in the portfolio is: 72.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All -5.42%
FATE Sell All 7.71%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 7.8% -1.06%
FATE Fate Therapeutics, Inc. Buy 9.38% 19.02%
RCM R1 RCM Inc. Buy 11.42% 7.83%
CYH Community Health Systems, Inc. Buy 12.91% -1.96%
RMD ResMed Inc. Buy 15.25% 7.5%
PODD Insulet Corporation Sell -6.42% -0.76%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.81% 2.95%
The percentage of cash held in the portfolio is: 55.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 7.91% 2.25%
FATE Fate Therapeutics, Inc. Buy 10.6% 37.02%
RCM R1 RCM Inc. Buy 10.27% -1.15%
CYH Community Health Systems, Inc. Buy 13.35% 3.34%
HQY HealthEquity, Inc. Buy 12.52% -3.09%
HCSG Healthcare Services Group, Inc. Buy 3.99% -1.12%
RMD ResMed Inc. Buy 14.27% 2.5%
PODD Insulet Corporation Sell -6.24% 0.31%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.97% -1.69%
The percentage of cash held in the portfolio is: 39.29%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 7.58%
PDSB Sell All 1.14%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 13.34% 8.33%
PDSB PDS Biotechnology Corporation Buy 10.08% -1.7%
BKD Brookdale Senior Living Inc. Buy 8.08% 3.44%
FATE Fate Therapeutics, Inc. Buy 10.3% 31.88%
RCM R1 RCM Inc. Buy 10.39% -1%
CYH Community Health Systems, Inc. Buy 13.23% 1.38%
HQY HealthEquity, Inc. Buy 12.63% -3.16%
HCSG Healthcare Services Group, Inc. Buy 4.05% -0.43%
RMD ResMed Inc. Buy 14.06% 0%
PODD Insulet Corporation Sell -6.28% 0.6%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.93% 0%
The percentage of cash held in the portfolio is: 16.06%
New Assets Added
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 12.92% 8.33%
PDSB PDS Biotechnology Corporation Buy 10.78% 8.52%
BKD Brookdale Senior Living Inc. Buy 7.9% 4.37%
FATE Fate Therapeutics, Inc. Buy 10.52% 39.07%
RCM R1 RCM Inc. Buy 9.9% -2.61%
CLDX Celldex Therapeutics, Inc. Buy 10.8% -4.26%
SMTI Sanara MedTech Inc. Buy 11.95% -5.45%
CYH Community Health Systems, Inc. Buy 12.87% 1.77%
HQY HealthEquity, Inc. Buy 12.43% -1.69%
HCSG Healthcare Services Group, Inc. Buy 3.94% 0%
PODD Insulet Corporation Sell -6.02% 1.61%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
RMD Buy All -5.84%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 12.98% 12.12%
PDSB PDS Biotechnology Corporation Buy 10.63% 10.23%
BKD Brookdale Senior Living Inc. Buy 7.76% 5.69%
FATE Fate Therapeutics, Inc. Buy 10.27% 39.85%
RCM R1 RCM Inc. Buy 9.85% -0.19%
PTGX Protagonist Therapeutics, Inc. Buy 10.53% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 11.12% 1.6%
SMTI Sanara MedTech Inc. Buy 12.26% 0%
CYH Community Health Systems, Inc. Buy 12.26% 0%
HQY HealthEquity, Inc. Buy 12.26% 0%
PODD Insulet Corporation Sell -5.89% 0.85%
RMD ResMed Inc. Sell -6.03% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RMD
  • SMTI
  • CYH
  • HQY
Assets Removed
Asset Action Perf %
ATRC Sell All -12.65%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 12.43% 7.58%
PDSB PDS Biotechnology Corporation Buy 10.77% 11.93%
BKD Brookdale Senior Living Inc. Buy 7.58% 3.44%
FATE Fate Therapeutics, Inc. Buy 10.18% 38.82%
ATRC AtriCure, Inc. Buy 9.43% -7%
RCM R1 RCM Inc. Buy 9.77% -0.84%
PTGX Protagonist Therapeutics, Inc. Buy 10.85% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 10.93% 0%
PODD Insulet Corporation Sell -5.81% 2.09%
The percentage of cash held in the portfolio is: 23.86%
New Assets Added
  • CLDX
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 12.5% 7.58%
PDSB PDS Biotechnology Corporation Buy 10.35% 6.96%
BKD Brookdale Senior Living Inc. Buy 7.64% 3.7%
FATE Fate Therapeutics, Inc. Buy 9.81% 33.16%
ATRC AtriCure, Inc. Buy 9.66% -5.18%
RCM R1 RCM Inc. Buy 9.99% 0.92%
PTGX Protagonist Therapeutics, Inc. Buy 10.99% 0%
PODD Insulet Corporation Sell -5.94% 0.3%
The percentage of cash held in the portfolio is: 34.98%
New Assets Added
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 12.91% 10.61%
PDSB PDS Biotechnology Corporation Buy 10.77% 10.8%
BKD Brookdale Senior Living Inc. Buy 7.61% 2.78%
FATE Fate Therapeutics, Inc. Buy 8.68% 17.22%
ATRC AtriCure, Inc. Buy 9.64% -5.85%
RCM R1 RCM Inc. Buy 10.16% 2.15%
PODD Insulet Corporation Sell -5.97% 0.37%
The percentage of cash held in the portfolio is: 46.19%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 13.4%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.86% 9.54%
OPK OPKO Health, Inc. Buy 13.28% 12.88%
PDSB PDS Biotechnology Corporation Buy 10.78% 9.94%
BKD Brookdale Senior Living Inc. Buy 7.55% 1.19%
FATE Fate Therapeutics, Inc. Buy 8.19% 9.77%
ATRC AtriCure, Inc. Buy 9.86% -4.47%
RCM R1 RCM Inc. Buy 10.23% 2%
PODD Insulet Corporation Sell -6.04% -0.04%
The percentage of cash held in the portfolio is: 34.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.79% 9.54%
OPK OPKO Health, Inc. Buy 13.47% 15.15%
ALT Altimmune, Inc. Buy 10.24% -12.43%
PDSB PDS Biotechnology Corporation Buy 10.68% 9.66%
BKD Brookdale Senior Living Inc. Buy 7.54% 1.59%
FATE Fate Therapeutics, Inc. Buy 8.22% 10.8%
ATRC AtriCure, Inc. Buy 10% -2.49%
RCM R1 RCM Inc. Buy 9.82% -1.46%
PODD Insulet Corporation Sell -6% 0%
The percentage of cash held in the portfolio is: 24.25%
New Assets Added
  • PODD
Assets Removed
Asset Action Perf %
FGEN Buy All -0.97%
CYH Sell All 17.81%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.39% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 12.06% 15.37%
OPK OPKO Health, Inc. Buy 12.22% 7.58%
ALT Altimmune, Inc. Buy 11.37% 0.13%
PDSB PDS Biotechnology Corporation Buy 10.77% 13.92%
WST West Pharmaceutical Services, Inc. Buy 11.2% -1.88%
BKD Brookdale Senior Living Inc. Buy 7.37% 2.25%
FATE Fate Therapeutics, Inc. Buy 8.26% 14.65%
ATRC AtriCure, Inc. Buy 9.87% -0.91%
RCM R1 RCM Inc. Buy 9.68% 0%
FGEN FibroGen, Inc. Sell -6.19% -3.88%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.29% 25%
VRDN Viridian Therapeutics, Inc. Buy 12.33% 20.89%
OPK OPKO Health, Inc. Buy 12.09% 9.09%
ALT Altimmune, Inc. Buy 12% 8.29%
BHVN Biohaven Ltd. Buy 9.82% 4.86%
PDSB PDS Biotechnology Corporation Buy 10.87% 17.76%
WST West Pharmaceutical Services, Inc. Buy 11% -1.26%
BKD Brookdale Senior Living Inc. Buy 7.09% 0.93%
FATE Fate Therapeutics, Inc. Buy 8.22% 16.97%
ATRC AtriCure, Inc. Buy 9.72% 0%
FGEN FibroGen, Inc. Sell -6.44% -10.68%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ATRC
Assets Removed
Asset Action Perf %
RARE Sell All 13.6%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
RARE Ultragenyx Pharmaceutical Inc. Buy 9.85% 11.57%
CYH Community Health Systems, Inc. Buy 11.3% 21.88%
VRDN Viridian Therapeutics, Inc. Buy 11.64% 11.2%
OPK OPKO Health, Inc. Buy 12.32% 8.33%
ALT Altimmune, Inc. Buy 12.02% 5.61%
BHVN Biohaven Ltd. Buy 10.22% 6.27%
PDSB PDS Biotechnology Corporation Buy 11.37% 20.03%
WST West Pharmaceutical Services, Inc. Buy 10.99% -3.96%
BKD Brookdale Senior Living Inc. Buy 7.22% 0%
FATE Fate Therapeutics, Inc. Buy 7.22% 0%
FGEN FibroGen, Inc. Sell -6.15% -2.91%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BKD
  • FATE
Assets Removed
Asset Action Perf %
APLS Buy All -10.22%
ACAD Sell All 13.54%
EGRX Sell All 33.26%
Assets Rebalanced
None
2024-07-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.09% 11.9%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.17% 34.37%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.15% 13.27%
CYH Community Health Systems, Inc. Buy 11.17% 18.75%
VRDN Viridian Therapeutics, Inc. Buy 11.17% 5.15%
OPK OPKO Health, Inc. Buy 12.07% 4.55%
ALT Altimmune, Inc. Buy 12.19% 5.61%
BHVN Biohaven Ltd. Buy 10.27% 5.28%
PDSB PDS Biotechnology Corporation Buy 11.17% 16.19%
WST West Pharmaceutical Services, Inc. Buy 11.24% -3.1%
FGEN FibroGen, Inc. Sell -6.12% -0.97%
APLS Apellis Pharmaceuticals, Inc. Sell -7.57% -8.93%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Buy All -25%
Assets Rebalanced
Asset Action Weight
BHVN Sell -1.88%
RARE Sell -2.22%
EGRX Sell -2.15%
PDSB Sell -2.24%
CYH Sell -3.95%
VRDN Sell -4.24%
WST Buy 8.21%
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.27% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.64% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 12.3% 10.14%
CYH Community Health Systems, Inc. Buy 15.09% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 14.69% -1.97%
PDSB PDS Biotechnology Corporation Buy 13.01% 10.23%
BHVN Biohaven Ltd. Buy 12.38% 4.89%
ALT Altimmune, Inc. Buy 12.12% 2.67%
OPK OPKO Health, Inc. Buy 12.25% 3.79%
WST West Pharmaceutical Services, Inc. Buy 3.12% 0%
FGEN FibroGen, Inc. Sell -5.89% 4.95%
SGMO Sangamo Therapeutics, Inc. Sell -8.35% -22.22%
APLS Apellis Pharmaceuticals, Inc. Sell -7.62% -7.16%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
Assets Removed
Asset Action Perf %
NVRO Buy All -10.68%
PAHC Buy All -6.77%
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.37% 7.75%
EGRX Eagle Pharmaceuticals, Inc. Buy 14.22% 34.82%
RARE Ultragenyx Pharmaceutical Inc. Buy 12.38% 6.55%
CYH Community Health Systems, Inc. Buy 14.14% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 14.48% -7.12%
PDSB PDS Biotechnology Corporation Buy 12.28% 0%
BHVN Biohaven Ltd. Buy 12.28% 0%
ALT Altimmune, Inc. Buy 12.28% 0%
OPK OPKO Health, Inc. Buy 12.28% 0%
NVRO Nevro Corp. Sell 14.51% -0.63%
FGEN FibroGen, Inc. Sell -5.65% 12.33%
SGMO Sangamo Therapeutics, Inc. Sell -7.9% -11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -7.63% -3.17%
PAHC Phibro Animal Health Corporation Sell -23.33% 0%
The percentage of cash held in the portfolio is: 14.28%
New Assets Added
  • PAHC
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.24% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.8% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.59% 0.9%
CYH Community Health Systems, Inc. Buy 14.1% 5.31%
VRDN Viridian Therapeutics, Inc. Buy 14.29% -7.27%
NVRO Nevro Corp. Sell 15% -5.28%
FGEN FibroGen, Inc. Sell -4.28% 32.91%
SGMO Sangamo Therapeutics, Inc. Sell -6.25% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -7.13% 2.42%
The percentage of cash held in the portfolio is: 39.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.4% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.18% 16.74%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.81% 2.79%
STAA STAAR Surgical Company Buy 12.09% 5.2%
CYH Community Health Systems, Inc. Buy 14.35% 7.19%
VRDN Viridian Therapeutics, Inc. Buy 14.19% -7.95%
NVRO Nevro Corp. Sell 14.95% -4.9%
FGEN FibroGen, Inc. Sell -4.6% 27.86%
SGMO Sangamo Therapeutics, Inc. Sell -6.25% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -7.05% 3.61%
The percentage of cash held in the portfolio is: 27.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.67% 1.01%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.81% 23.44%
MNKD MannKind Corporation Buy 8.97% -6.26%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.88% 3.19%
STAA STAAR Surgical Company Buy 11.81% 12.05%
CYH Community Health Systems, Inc. Buy 12.75% 3.75%
ARDX Ardelyx, Inc. Buy 14.19% 2.16%
CHRS Coherus BioSciences, Inc. Buy 12.93% -6.94%
NVRO Nevro Corp. Sell 14.15% -8.17%
VRDN Viridian Therapeutics, Inc. Buy 14.15% 0%
FGEN FibroGen, Inc. Sell -4.37% 25.24%
SGMO Sangamo Therapeutics, Inc. Sell -5.91% 8.33%
APLS Apellis Pharmaceuticals, Inc. Sell -6.71% 0%
The percentage of cash held in the portfolio is: -4.3%
New Assets Added
  • APLS
  • NVRO
  • VRDN
Assets Removed
Asset Action Perf %
MODV Buy All -8.11%
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.75% 2.33%
MNKD MannKind Corporation Buy 9.16% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.91% 25%
STAA STAAR Surgical Company Buy 11.81% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.82% 3.14%
CYH Community Health Systems, Inc. Buy 12.84% 5%
ARDX Ardelyx, Inc. Buy 13.82% 0%
CHRS Coherus BioSciences, Inc. Buy 13.82% 0%
NVRO Nevro Corp. Sell -6.13% -5.78%
MODV ModivCare Inc. Sell -5.99% -4.83%
FGEN FibroGen, Inc. Sell -5.04% 13.4%
SGMO Sangamo Therapeutics, Inc. Sell -6.42% 0%
The percentage of cash held in the portfolio is: 29.65%
New Assets Added
  • SGMO
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.05% 3.09%
MNKD MannKind Corporation Buy 9.5% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.92% 12.05%
STAA STAAR Surgical Company Buy 11.87% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.16% 3.94%
CYH Community Health Systems, Inc. Buy 12.52% 0%
NVRO Nevro Corp. Sell -6.23% -5.03%
MODV ModivCare Inc. Sell -5.9% -0.84%
FGEN FibroGen, Inc. Sell -5.96% 0%
The percentage of cash held in the portfolio is: 52.07%
New Assets Added
  • FGEN
  • CYH
Assets Removed
Asset Action Perf %
AVXL Buy All -12.3%
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.6% -2.39%
MNKD MannKind Corporation Buy 9.4% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.8% 9.82%
STAA STAAR Surgical Company Buy 11.65% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.02% 1.71%
NVRO Nevro Corp. Sell -6.41% -7.16%
MODV ModivCare Inc. Sell -5.9% 0%
AVXL Anavex Life Sciences Corp. Sell -5.9% 0%
The percentage of cash held in the portfolio is: 65.75%
New Assets Added
  • MODV
  • AVXL
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.69% -1.76%
MNKD MannKind Corporation Buy 9.51% -3.5%
FGEN FibroGen, Inc. Buy 9.61% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.01% 1.56%
STAA STAAR Surgical Company Buy 10.86% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.86% 0%
NVRO Nevro Corp. Sell -6% 0%
The percentage of cash held in the portfolio is: 45.45%
New Assets Added
  • NVRO
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.8% 0%
MNKD MannKind Corporation Buy 9.8% 0%
FGEN FibroGen, Inc. Buy 9.8% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-06-07 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
VKTX Buy All 20.34%
Assets Rebalanced
None
2024-05-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VKTX Viking Therapeutics, Inc. Sell -7.38% 10.54%
The percentage of cash held in the portfolio is: 107.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Buy All 14.16%
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Sell -2.47% 13.87%
VKTX Viking Therapeutics, Inc. Sell -7.64% 7.6%
The percentage of cash held in the portfolio is: 110.11%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Buy All -12.87%
Assets Rebalanced
None
2024-05-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Sell -2.52% 12.37%
VKTX Viking Therapeutics, Inc. Sell -7.83% 5.36%
TVTX Travere Therapeutics, Inc. Sell -10.3% -11.55%
The percentage of cash held in the portfolio is: 120.65%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDRX Buy All -16.51%
ILMN Buy All 6.9%
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.42% -0.53%
ILMN Illumina, Inc. Sell -5.09% 5.62%
VRDN Viridian Therapeutics, Inc. Sell -2.45% 12.94%
VKTX Viking Therapeutics, Inc. Sell -7.37% 9.14%
TVTX Travere Therapeutics, Inc. Sell -9.2% -1.65%
The percentage of cash held in the portfolio is: 129.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMCL Sell All 8.3%
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 12.73% 5.21%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.62% -3.46%
ILMN Illumina, Inc. Sell -5.09% 6.18%
VRDN Viridian Therapeutics, Inc. Sell -2.48% 12.58%
VKTX Viking Therapeutics, Inc. Sell -7.28% 10.85%
TVTX Travere Therapeutics, Inc. Sell -9.53% -4.62%
The percentage of cash held in the portfolio is: 117.27%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -7.38%
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 12.94% 7%
VCYT Veracyte, Inc. Buy 10.77% -3.91%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.49% -1.2%
ILMN Illumina, Inc. Sell -5.16% 4.81%
VRDN Viridian Therapeutics, Inc. Sell -2.59% 8.7%
VKTX Viking Therapeutics, Inc. Sell -7.44% 8.76%
TVTX Travere Therapeutics, Inc. Sell -9.86% -8.25%
The percentage of cash held in the portfolio is: 106.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All -2.32%
ACRS Sell All -8.73%
SGMO Sell All 18.52%
INGN Sell All 22.55%
Assets Rebalanced
None
2024-05-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 12.38% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 12.71% 11.11%
INGN Inogen, Inc. Buy 11.97% 22.13%
OMCL Omnicell, Inc. Buy 12.9% 5.91%
VCYT Veracyte, Inc. Buy 10.93% -3.2%
PODD Insulet Corporation Buy 20.25% -1.4%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.61% -2.53%
ILMN Illumina, Inc. Sell -5.21% 4.62%
VRDN Viridian Therapeutics, Inc. Sell -2.64% 7.4%
VKTX Viking Therapeutics, Inc. Sell -7.65% 6.99%
TVTX Travere Therapeutics, Inc. Sell -10.01% -9.08%
The percentage of cash held in the portfolio is: 49.97%
New Assets Added
None
Assets Removed
Asset Action Perf %
SENS Sell All -3.49%
Assets Rebalanced
None
2024-05-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
SENS Senseonics Holdings, Inc. Buy 12.09% -3.7%
ACRS Aclaris Therapeutics, Inc. Buy 12.42% -5.56%
SGMO Sangamo Therapeutics, Inc. Buy 12.86% 12.96%
INGN Inogen, Inc. Buy 12.12% 24.26%
OMCL Omnicell, Inc. Buy 12.37% 1.99%
VCYT Veracyte, Inc. Buy 11.14% -0.89%
PODD Insulet Corporation Buy 20.3% -0.67%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.61% -3.2%
ILMN Illumina, Inc. Sell -5.23% 3.8%
VRDN Viridian Therapeutics, Inc. Sell -2.76% 2.73%
VKTX Viking Therapeutics, Inc. Sell -8% 2.24%
TVTX Travere Therapeutics, Inc. Sell -9.3% -1.82%
The percentage of cash held in the portfolio is: 37.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -0.79%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 12.06% -0.79%
SENS Senseonics Holdings, Inc. Buy 12.24% -0.41%
ACRS Aclaris Therapeutics, Inc. Buy 12.16% -5.56%
SGMO Sangamo Therapeutics, Inc. Buy 13.42% 20.37%
INGN Inogen, Inc. Buy 11.96% 25.25%
OMCL Omnicell, Inc. Buy 11.99% 1.03%
VCYT Veracyte, Inc. Buy 11.19% 1.69%
PODD Insulet Corporation Buy 20.22% 1.02%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.36% -0.53%
ILMN Illumina, Inc. Sell -5.24% 1.55%
VRDN Viridian Therapeutics, Inc. Sell -2.69% 3.31%
VKTX Viking Therapeutics, Inc. Sell -7.77% 2.98%
TVTX Travere Therapeutics, Inc. Sell -8.94% 0%
The percentage of cash held in the portfolio is: 24.76%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
NVRO Buy All -0.71%
IBRX Sell All -14.91%
PTCT Sell All 15.84%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 12.03% 19.11%
CARA Cara Therapeutics, Inc. Buy 12.86% 6.48%
IBRX ImmunityBio, Inc. Buy 10.56% -13.79%
SENS Senseonics Holdings, Inc. Buy 12.34% 1.03%
ACRS Aclaris Therapeutics, Inc. Buy 11.99% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 12.52% 12.96%
INGN Inogen, Inc. Buy 12.05% 26.95%
OMCL Omnicell, Inc. Buy 12.4% 5.08%
VCYT Veracyte, Inc. Buy 11.37% 4%
PODD Insulet Corporation Buy 19.89% 0%
NVRO Nevro Corp. Sell -8.23% 1.33%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.53% -4.53%
ILMN Illumina, Inc. Sell -5.37% -1.45%
VRDN Viridian Therapeutics, Inc. Sell -2.91% -5.18%
VKTX Viking Therapeutics, Inc. Sell -7.96% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VKTX
  • PODD
Assets Removed
Asset Action Perf %
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.94% 17.82%
CARA Cara Therapeutics, Inc. Buy 12.18% 0.53%
IBRX ImmunityBio, Inc. Buy 11.07% -9.9%
SENS Senseonics Holdings, Inc. Buy 12.48% 1.85%
ACRS Aclaris Therapeutics, Inc. Buy 12.02% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 11.94% 7.41%
INGN Inogen, Inc. Buy 11.94% 25.39%
OMCL Omnicell, Inc. Buy 11.73% -0.86%
VCYT Veracyte, Inc. Buy 11.48% 4.67%
MD Pediatrix Medical Group, Inc. Buy 12.6% -3.87%
NVRO Nevro Corp. Sell -7.8% 6.71%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.3% 0.13%
ILMN Illumina, Inc. Sell -5.41% -1.94%
VRDN Viridian Therapeutics, Inc. Sell -2.84% -2.59%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
ITGR Buy All -7.43%
Assets Rebalanced
Asset Action Weight
IBRX Sell -1.97%
PTCT Sell -1.82%
SGMO Sell -2.02%
INGN Sell -5.12%
MD Buy 1.39%
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 13.13% 10.96%
IBRX ImmunityBio, Inc. Buy 14.07% -4%
CARA Cara Therapeutics, Inc. Buy 12.18% -0.79%
SENS Senseonics Holdings, Inc. Buy 11.32% -8.83%
ACRS Aclaris Therapeutics, Inc. Buy 12.18% -6.35%
INGN Inogen, Inc. Buy 17.23% 25.04%
SGMO Sangamo Therapeutics, Inc. Buy 13.41% 1.85%
OMCL Omnicell, Inc. Buy 12.26% 2.22%
MD Pediatrix Medical Group, Inc. Buy 11.11% 0%
VCYT Veracyte, Inc. Buy 11.11% 0%
NVRO Nevro Corp. Sell -7.63% 9.98%
ITGR Integer Holdings Corporation Sell -8.71% -2.84%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.53% -2.8%
ILMN Illumina, Inc. Sell -5.38% 0.04%
VRDN Viridian Therapeutics, Inc. Sell -2.9% -3.09%
The percentage of cash held in the portfolio is: 2.15%
New Assets Added
  • MD
  • VCYT
Assets Removed
None
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 13.5% 12.88%
IBRX ImmunityBio, Inc. Buy 13.38% -9.68%
CARA Cara Therapeutics, Inc. Buy 11.75% -5.29%
SENS Senseonics Holdings, Inc. Buy 12.01% -4.31%
ACRS Aclaris Therapeutics, Inc. Buy 12.21% -7.14%
INGN Inogen, Inc. Buy 16.72% 20%
SGMO Sangamo Therapeutics, Inc. Buy 13.8% 3.7%
OMCL Omnicell, Inc. Buy 12.12% -0.03%
NVRO Nevro Corp. Sell -7.41% 13.52%
ITGR Integer Holdings Corporation Sell -8.91% -4.01%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.64% -3.73%
ILMN Illumina, Inc. Sell -5.33% 2.03%
VRDN Viridian Therapeutics, Inc. Sell -2.84% 0.07%
The percentage of cash held in the portfolio is: 24.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
IOVA Sell All -12.24%
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 12.7% 8.68%
IBRX ImmunityBio, Inc. Buy 12.98% -10.34%
CARA Cara Therapeutics, Inc. Buy 12.19% 0.53%
SENS Senseonics Holdings, Inc. Buy 12.11% -1.23%
IOVA Iovance Biotherapeutics, Inc. Buy 12.25% 7.6%
ACRS Aclaris Therapeutics, Inc. Buy 12.49% -2.78%
INGN Inogen, Inc. Buy 16.78% 23.26%
SGMO Sangamo Therapeutics, Inc. Buy 12.52% -3.7%
OMCL Omnicell, Inc. Buy 11.89% 0.4%
NVRO Nevro Corp. Sell -7.77% 7.16%
ITGR Integer Holdings Corporation Sell -8.72% -4.24%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.48% -3.2%
ILMN Illumina, Inc. Sell -5.25% 1.3%
VRDN Viridian Therapeutics, Inc. Sell -2.78% 0%
The percentage of cash held in the portfolio is: 14.09%
New Assets Added
  • VRDN
Assets Removed
Asset Action Perf %
ACHC Buy All -6.61%
CDMO Sell All 7.67%
Assets Rebalanced
None
2024-05-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 12.8% 11.27%
IBRX ImmunityBio, Inc. Buy 13.1% -8.12%
CDMO Avid Bioservices, Inc. Buy 12.8% 15.87%
CARA Cara Therapeutics, Inc. Buy 12.5% 4.76%
SENS Senseonics Holdings, Inc. Buy 12.42% 2.87%
IOVA Iovance Biotherapeutics, Inc. Buy 12.53% 11.84%
ACRS Aclaris Therapeutics, Inc. Buy 13.45% 6.35%
INGN Inogen, Inc. Buy 13.88% 3.55%
SGMO Sangamo Therapeutics, Inc. Buy 12.8% 0%
OMCL Omnicell, Inc. Buy 11.72% 0.56%
NVRO Nevro Corp. Sell -8.39% -1.86%
ITGR Integer Holdings Corporation Sell -8.51% -3.25%
ACHC Acadia Healthcare Company, Inc. Sell -2.64% -1.98%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.23% 0%
ILMN Illumina, Inc. Sell -5.23% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
  • ILMN
Assets Removed
None
Assets Rebalanced
Asset Action Weight
ACRS Buy 0.89%
INGN Buy 1.2%
SGMO Buy 1.6%
PTCT Buy 1.61%
CDMO Buy 1.66%
CARA Buy 1.76%
2024-05-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.74% 15.37%
IBRX ImmunityBio, Inc. Buy 12.53% -13.13%
CARA Cara Therapeutics, Inc. Buy 10.84% 4.5%
CDMO Avid Bioservices, Inc. Buy 10.84% 11.38%
SENS Senseonics Holdings, Inc. Buy 12.64% 3.49%
ACRS Aclaris Therapeutics, Inc. Buy 11.79% 3.97%
IOVA Iovance Biotherapeutics, Inc. Buy 12.59% 11.04%
INGN Inogen, Inc. Buy 11.56% 1.99%
SGMO Sangamo Therapeutics, Inc. Buy 11.13% -1.85%
OMCL Omnicell, Inc. Buy 11.74% -0.5%
NVRO Nevro Corp. Sell -8.21% 1.5%
ITGR Integer Holdings Corporation Sell -8.5% -1.96%
ACHC Acadia Healthcare Company, Inc. Sell -2.68% -2.51%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATRI Buy All -10.12%
Assets Rebalanced
Asset Action Weight
CARA Sell -1.75%
CDMO Sell -2.59%
PTCT Sell -2.29%
OMCL Sell -4.55%
IBRX Buy 1.27%
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 13.69% 15.54%
IBRX ImmunityBio, Inc. Buy 11.96% 1.78%
CDMO Avid Bioservices, Inc. Buy 12.83% 9.13%
CARA Cara Therapeutics, Inc. Buy 12.1% 2.94%
SENS Senseonics Holdings, Inc. Buy 12.35% 3.68%
INGN Inogen, Inc. Buy 11.21% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 11.93% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 12.05% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 11.37% 2.93%
OMCL Omnicell, Inc. Buy 15.96% 0%
ATRI Atrion Corporation Sell -8.54% -5.05%
NVRO Nevro Corp. Sell -8.11% 0.27%
ITGR Integer Holdings Corporation Sell -8.25% -1.54%
ACHC Acadia Healthcare Company, Inc. Sell -2.55% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ACHC
  • OMCL
Assets Removed
Asset Action Perf %
SMMT Sell All 13.73%
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 14.68% 19.57%
SMMT Summit Therapeutics Inc. Buy 14.95% 21.76%
IBRX ImmunityBio, Inc. Buy 11.56% -5.01%
CDMO Avid Bioservices, Inc. Buy 12.35% 1.46%
CARA Cara Therapeutics, Inc. Buy 12.22% 0.4%
SENS Senseonics Holdings, Inc. Buy 11.73% -4.93%
INGN Inogen, Inc. Buy 11.45% 0%
ACRS Aclaris Therapeutics, Inc. Buy 11.45% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 11.45% 0%
SGMO Sangamo Therapeutics, Inc. Buy 11.45% 0%
ATRI Atrion Corporation Sell -9.1% -8.07%
NVRO Nevro Corp. Sell -7.74% 8.04%
ITGR Integer Holdings Corporation Sell -8.43% -0.18%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
Assets Removed
Asset Action Perf %
NUTX Buy All 37.91%
FATE Buy All 34.77%
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 14.35% 12.53%
SMMT Summit Therapeutics Inc. Buy 12.99% 1.81%
IBRX ImmunityBio, Inc. Buy 11.24% -11.12%
CDMO Avid Bioservices, Inc. Buy 12.76% 0.93%
CARA Cara Therapeutics, Inc. Buy 12.58% -0.53%
SENS Senseonics Holdings, Inc. Buy 12.81% 0%
NUTX Nutex Health Inc. Sell -1.76% 38.01%
FATE Fate Therapeutics, Inc. Sell -1.79% 37%
ATRI Atrion Corporation Sell -9.37% -7.16%
NVRO Nevro Corp. Sell -8.17% 6.54%
ITGR Integer Holdings Corporation Sell -8.91% -1.87%
The percentage of cash held in the portfolio is: 53.27%
New Assets Added
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 14.31% 12.5%
SMMT Summit Therapeutics Inc. Buy 12.79% 0.52%
IBRX ImmunityBio, Inc. Buy 12.61% 0%
CDMO Avid Bioservices, Inc. Buy 12.61% 0%
CARA Cara Therapeutics, Inc. Buy 12.61% 0%
NUTX Nutex Health Inc. Sell -1.82% 35.86%
FATE Fate Therapeutics, Inc. Sell -1.83% 35.57%
ATRI Atrion Corporation Sell -9.27% -6.33%
NVRO Nevro Corp. Sell -8.8% -0.88%
ITGR Integer Holdings Corporation Sell -9.12% -4.55%
The percentage of cash held in the portfolio is: 65.91%
New Assets Added
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 12.8% 0%
SMMT Summit Therapeutics Inc. Buy 12.8% 0%
NUTX Nutex Health Inc. Sell -1.94% 32.17%
FATE Fate Therapeutics, Inc. Sell -1.73% 39.39%
ATRI Atrion Corporation Sell -8.78% 0%
NVRO Nevro Corp. Sell -8.78% 0%
ITGR Integer Holdings Corporation Sell -8.78% 0%
The percentage of cash held in the portfolio is: 104.4%
New Assets Added
  • ATRI
  • NVRO
  • ITGR
  • PTCT
  • SMMT
Assets Removed
None
Assets Rebalanced
None
2024-04-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Sell -2.03% 29.41%
FATE Fate Therapeutics, Inc. Sell -2.19% 23.76%
The percentage of cash held in the portfolio is: 104.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All -6.11%
Assets Rebalanced
None
2024-04-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.72% -6.11%
NUTX Nutex Health Inc. Sell -1.93% 32.89%
FATE Fate Therapeutics, Inc. Sell -2.31% 19.62%
The percentage of cash held in the portfolio is: 93.52%
New Assets Added
None
Assets Removed
Asset Action Perf %
UTHR Buy All -3.14%
Assets Rebalanced
None
2024-04-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.87% -4.58%
UTHR United Therapeutics Corporation Sell -18.69% -2.43%
NUTX Nutex Health Inc. Sell -1.94% 32.17%
FATE Fate Therapeutics, Inc. Sell -2.41% 15.95%
The percentage of cash held in the portfolio is: 112.17%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACRS Sell All -2.38%
KIDS Sell All 3.21%
ANGO Sell All 11.05%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 12.2% -3.97%
KIDS OrthoPediatrics Corp. Buy 12.02% 5.11%
ANGO AngioDynamics, Inc. Buy 10.86% 10.7%
OPK OPKO Health, Inc. Buy 10.69% -6.11%
UTHR United Therapeutics Corporation Sell -18.66% -2.33%
NUTX Nutex Health Inc. Sell -1.57% 45.39%
FATE Fate Therapeutics, Inc. Sell -2.58% 10.05%
The percentage of cash held in the portfolio is: 77.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -9.75%
Assets Rebalanced
None
2024-04-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 12.12% -3.97%
TNDM Tandem Diabetes Care, Inc. Buy 11.45% -5.1%
KIDS OrthoPediatrics Corp. Buy 12.19% 7.32%
ANGO AngioDynamics, Inc. Buy 10.9% 11.75%
OPK OPKO Health, Inc. Buy 10.63% -6.11%
UTHR United Therapeutics Corporation Sell -18.34% -1.25%
NUTX Nutex Health Inc. Sell -1.96% 31.25%
FATE Fate Therapeutics, Inc. Sell -2.62% 7.97%
The percentage of cash held in the portfolio is: 65.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
RVNC Sell All -16.06%
Assets Rebalanced
None
2024-04-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 11.56% -7.94%
TNDM Tandem Diabetes Care, Inc. Buy 11.76% -2.07%
KIDS OrthoPediatrics Corp. Buy 12.4% 9.67%
ANGO AngioDynamics, Inc. Buy 11.66% 20.18%
RVNC Revance Therapeutics, Inc. Buy 11.16% -10.37%
OPK OPKO Health, Inc. Buy 10.92% -3.05%
UTHR United Therapeutics Corporation Sell -18.66% -3.51%
NUTX Nutex Health Inc. Sell -2.83% 0%
FATE Fate Therapeutics, Inc. Sell -2.83% 0%
The percentage of cash held in the portfolio is: 54.88%
New Assets Added
  • NUTX
  • FATE
Assets Removed
Asset Action Perf %
LXRX Sell All -15.83%
Assets Rebalanced
None
2024-04-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 11.62% -5.56%
TNDM Tandem Diabetes Care, Inc. Buy 11.62% -1.16%
KIDS OrthoPediatrics Corp. Buy 11.62% 4.94%
ANGO AngioDynamics, Inc. Buy 11.62% 22.28%
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.62% -13.75%
RVNC Revance Therapeutics, Inc. Buy 11.62% -4.67%
OPK OPKO Health, Inc. Buy 11.62% 5.34%
UTHR United Therapeutics Corporation Sell -18.23% -3.19%
The percentage of cash held in the portfolio is: 36.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Buy All -1111.05%
Assets Rebalanced
Asset Action Weight
ACRS Sell -15.51%
LXRX Sell -16.2%
TNDM Sell -16.77%
KIDS Sell -18.52%
RVNC Sell -19.12%
ANGO Sell -23.51%
OPK Sell -26.67%
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.12% 8.6%
TNDM Tandem Diabetes Care, Inc. Buy 9.71% -5.1%
KIDS OrthoPediatrics Corp. Buy 9.43% -7.9%
ACRS Aclaris Therapeutics, Inc. Buy 9.91% -3.17%
RVNC Revance Therapeutics, Inc. Buy 10.53% -8.33%
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.58% -7.92%
OPK OPKO Health, Inc. Buy 13.35% 3.05%
UTHR United Therapeutics Corporation Sell -6.26% 0.5%
NUTX Nutex Health Inc. Sell -5.97% 1.05%
The percentage of cash held in the portfolio is: 37.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -5.57%
Assets Rebalanced
None
2024-04-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.34% 2.28%
TNDM Tandem Diabetes Care, Inc. Buy 9.69% -4.11%
KIDS OrthoPediatrics Corp. Buy 9.84% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 10.11% 0%
VCYT Veracyte, Inc. Buy 10.07% -0.37%
RVNC Revance Therapeutics, Inc. Buy 10.91% -3.86%
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.78% -5%
OPK OPKO Health, Inc. Buy 12.79% 0%
UTHR United Therapeutics Corporation Sell -6.18% 0.64%
NUTX Nutex Health Inc. Sell -5.96% 0%
The percentage of cash held in the portfolio is: 27.59%
New Assets Added
  • NUTX
  • OPK
Assets Removed
Asset Action Perf %
OFIX Sell All -3.17%
ATRI Sell All -11.81%
Assets Rebalanced
None
2024-03-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.05% 2.98%
TNDM Tandem Diabetes Care, Inc. Buy 9.79% 0.31%
KIDS OrthoPediatrics Corp. Buy 9.82% 0.66%
ACRS Aclaris Therapeutics, Inc. Buy 9.6% -1.59%
VCYT Veracyte, Inc. Buy 9.96% 2.03%
ATRI Atrion Corporation Buy 10.96% 0%
OFIX Orthofix Medical Inc. Buy 10.96% 0%
RVNC Revance Therapeutics, Inc. Buy 10.96% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.96% 0%
UTHR United Therapeutics Corporation Sell -6% 0%
The percentage of cash held in the portfolio is: 12.96%
New Assets Added
  • UTHR
  • ATRI
  • OFIX
  • RVNC
  • LXRX
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 9.8% 0%
TNDM Tandem Diabetes Care, Inc. Buy 9.8% 0%
KIDS OrthoPediatrics Corp. Buy 9.8% 0%
ACRS Aclaris Therapeutics, Inc. Buy 9.8% 0%
VCYT Veracyte, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 51%
New Assets Added
  • ANGO
  • TNDM
  • KIDS
  • ACRS
  • VCYT
Assets Removed
Asset Action Perf %
SMTI Buy All -1.39%
BAX Sell All -0.7%
OMCL Sell All 5.22%
Assets Rebalanced
None
2024-03-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 11.69% -2.44%
OMCL Omnicell, Inc. Buy 11.93% 0.5%
SMTI Sanara MedTech Inc. Sell -4.57% -1.69%
The percentage of cash held in the portfolio is: 80.94%
New Assets Added
None
Assets Removed
Asset Action Perf %
RDNT Sell All 8.32%
THC Sell All 8.23%
NTRA Sell All 3.25%
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
RDNT RadNet, Inc. Buy 12.49% 6.45%
THC Tenet Healthcare Corporation Buy 12.03% 8.8%
NTRA Natera, Inc. Buy 11.64% 3.9%
BAX Baxter International Inc. Buy 11.68% -2.7%
OMCL Omnicell, Inc. Buy 11.95% 0.5%
SMTI Sanara MedTech Inc. Sell -4.61% -2.45%
The percentage of cash held in the portfolio is: 44.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
CUTR Buy All -7.11%
QTRX Sell All -9.55%
Assets Rebalanced
None
2024-03-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
RDNT RadNet, Inc. Buy 12.01% 2.59%
THC Tenet Healthcare Corporation Buy 12% 8.73%
NTRA Natera, Inc. Buy 11.41% 2.07%
QTRX Quanterix Corporation Buy 13.22% -3.95%
BAX Baxter International Inc. Buy 11.68% -2.42%
OMCL Omnicell, Inc. Buy 11.8% -0.54%
CUTR Cutera, Inc. Sell -2.5% -0.51%
SMTI Sanara MedTech Inc. Sell -4.54% -1.22%
The percentage of cash held in the portfolio is: 34.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAVA Buy All -10.84%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
RDNT RadNet, Inc. Buy 11.89% 1.08%
THC Tenet Healthcare Corporation Buy 11.81% 6.46%
NTRA Natera, Inc. Buy 11.32% 0.79%
QTRX Quanterix Corporation Buy 13.09% -5.31%
BAX Baxter International Inc. Buy 11.62% -3.37%
OMCL Omnicell, Inc. Buy 11.79% -1.15%
CUTR Cutera, Inc. Sell -2.32% 7.11%
SMTI Sanara MedTech Inc. Sell -4.46% 1.03%
SAVA Cassava Sciences, Inc. Sell -4.83% -7.26%
The percentage of cash held in the portfolio is: 40.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
ABUS Sell All -5.93%
Assets Rebalanced
None
2024-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
RDNT RadNet, Inc. Buy 11.81% 0.23%
THC Tenet Healthcare Corporation Buy 11.64% 4.78%
NTRA Natera, Inc. Buy 11.27% 0.12%
QTRX Quanterix Corporation Buy 13.1% -5.42%
BAX Baxter International Inc. Buy 11.66% -3.21%
OMCL Omnicell, Inc. Buy 11.9% -0.36%
ABUS Arbutus Biopharma Corporation Buy 12.3% -2.96%
CUTR Cutera, Inc. Sell -2.53% -1.02%
SMTI Sanara MedTech Inc. Sell -4.54% -0.57%
SAVA Cassava Sciences, Inc. Sell -4.85% -7.31%
The percentage of cash held in the portfolio is: 28.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTGX Sell All 1.76%
Assets Rebalanced
None
2024-03-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 10.93% -0.46%
RDNT RadNet, Inc. Buy 11.69% -1.08%
THC Tenet Healthcare Corporation Buy 11.82% 6.1%
NTRA Natera, Inc. Buy 11.07% -1.9%
QTRX Quanterix Corporation Buy 13.05% -6.02%
BAX Baxter International Inc. Buy 11.81% -2.26%
OMCL Omnicell, Inc. Buy 11.89% -0.72%
ABUS Arbutus Biopharma Corporation Buy 12.29% -3.33%
CUTR Cutera, Inc. Sell -2.49% 1.02%
SMTI Sanara MedTech Inc. Sell -4.47% 1.17%
SAVA Cassava Sciences, Inc. Sell -4.72% -4.28%
The percentage of cash held in the portfolio is: 17.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -15.74%
Assets Rebalanced
None
2024-03-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 11.26% 6.04%
RDNT RadNet, Inc. Buy 11.6% 1.53%
MRSN Mersana Therapeutics, Inc. Buy 12.83% -3.37%
THC Tenet Healthcare Corporation Buy 11.47% 6.46%
NTRA Natera, Inc. Buy 10.85% -0.5%
QTRX Quanterix Corporation Buy 12.59% -6.27%
BAX Baxter International Inc. Buy 11.6% -0.72%
OMCL Omnicell, Inc. Buy 11.57% -0.11%
ABUS Arbutus Biopharma Corporation Buy 12.29% 0%
CUTR Cutera, Inc. Sell -2.44% -0.51%
SMTI Sanara MedTech Inc. Sell -4.44% -1.39%
SAVA Cassava Sciences, Inc. Sell -4.56% -4.08%
The percentage of cash held in the portfolio is: 5.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDOC Buy All 3.2%
Assets Rebalanced
None
2024-03-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 11.1% 4.88%
RDNT RadNet, Inc. Buy 11.82% 3.77%
MRSN Mersana Therapeutics, Inc. Buy 12.57% -5.05%
THC Tenet Healthcare Corporation Buy 11.38% 6.01%
NTRA Natera, Inc. Buy 11.04% 1.57%
QTRX Quanterix Corporation Buy 12.79% -4.49%
BAX Baxter International Inc. Buy 11.62% -0.23%
OMCL Omnicell, Inc. Buy 11.66% 1.04%
ABUS Arbutus Biopharma Corporation Buy 12.21% -0.37%
TDOC Teladoc Health, Inc. Sell -7.79% 1.73%
CUTR Cutera, Inc. Sell -2.48% -2.54%
SMTI Sanara MedTech Inc. Sell -4.37% -0.16%
SAVA Cassava Sciences, Inc. Sell -4.58% -4.89%
The percentage of cash held in the portfolio is: 13.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Sell All -5.28%
Assets Rebalanced
None
2024-03-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 11.06% 6.46%
RDNT RadNet, Inc. Buy 11.72% 4.87%
MRSN Mersana Therapeutics, Inc. Buy 12.64% -2.69%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.43% 0.33%
THC Tenet Healthcare Corporation Buy 11.03% 4.66%
NTRA Natera, Inc. Buy 10.63% -0.39%
QTRX Quanterix Corporation Buy 12.42% -5.45%
BAX Baxter International Inc. Buy 11.64% 1.81%
OMCL Omnicell, Inc. Buy 11.64% 2.73%
ABUS Arbutus Biopharma Corporation Buy 12.16% 1.11%
TDOC Teladoc Health, Inc. Sell -7.67% 1.41%
CUTR Cutera, Inc. Sell -2.39% -0.51%
SMTI Sanara MedTech Inc. Sell -4.25% 0.73%
SAVA Cassava Sciences, Inc. Sell -4.05% 5.34%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAGE Buy All 5.07%
Assets Rebalanced
Asset Action Weight
THC Sell -1.32%
NTRA Sell -2.31%
BAX Sell -5.18%
OMCL Sell -5.34%
QTRX Buy 1.79%
2024-03-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 11.07% 8.46%
MRSN Mersana Therapeutics, Inc. Buy 12.58% -1.52%
NTRA Natera, Inc. Buy 13.09% 2.52%
THC Tenet Healthcare Corporation Buy 12.07% 4.1%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.47% 2.41%
RDNT RadNet, Inc. Buy 12.03% 9.45%
QTRX Quanterix Corporation Buy 11.05% -0.07%
BAX Baxter International Inc. Buy 16.43% 1.16%
OMCL Omnicell, Inc. Buy 16.4% 0.97%
ABUS Arbutus Biopharma Corporation Buy 11.82% 0%
SAGE Sage Therapeutics, Inc. Sell -11.89% 8.17%
TDOC Teladoc Health, Inc. Sell -7.51% 1.85%
CUTR Cutera, Inc. Sell -2.41% -3.05%
SMTI Sanara MedTech Inc. Sell -4.21% -0.11%
SAVA Cassava Sciences, Inc. Sell -4.08% 2.97%
The percentage of cash held in the portfolio is: 2.1%
New Assets Added
  • ABUS
Assets Removed
Asset Action Perf %
RCM Sell All 27.04%
Assets Rebalanced
None
2024-03-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 11.79% 24.71%
PTGX Protagonist Therapeutics, Inc. Buy 11.28% 9.8%
MRSN Mersana Therapeutics, Inc. Buy 12.42% -3.37%
NTRA Natera, Inc. Buy 12.97% 0.91%
THC Tenet Healthcare Corporation Buy 12.05% 3.23%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.5% 2.02%
RDNT RadNet, Inc. Buy 12.09% 9.36%
QTRX Quanterix Corporation Buy 11.21% 0.75%
BAX Baxter International Inc. Buy 16.34% 0%
OMCL Omnicell, Inc. Buy 16.34% 0%
SAGE Sage Therapeutics, Inc. Sell -11.83% 9.2%
TDOC Teladoc Health, Inc. Sell -7.18% 6.78%
CUTR Cutera, Inc. Sell -2.52% -7.11%
SMTI Sanara MedTech Inc. Sell -4.24% 0%
SAVA Cassava Sciences, Inc. Sell -4.24% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • SAVA
  • BAX
  • OMCL
Assets Removed
Asset Action Perf %
NUTX Sell All -12.3%
BRKR Sell All 13.09%
Assets Rebalanced
None
2024-03-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 11.47% -11.48%
BRKR Bruker Corporation Buy 11.97% 12.64%
RCM R1 RCM Inc. Buy 11.97% 25.07%
PTGX Protagonist Therapeutics, Inc. Buy 11.31% 8.71%
MRSN Mersana Therapeutics, Inc. Buy 12.64% -2.86%
NTRA Natera, Inc. Buy 12.75% -2%
THC Tenet Healthcare Corporation Buy 11.97% 1.35%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.19% -1.89%
RDNT RadNet, Inc. Buy 11.97% 6.94%
QTRX Quanterix Corporation Buy 11.32% 0.5%
SAGE Sage Therapeutics, Inc. Sell -12.03% 8.77%
TDOC Teladoc Health, Inc. Sell -7.17% 7.99%
CUTR Cutera, Inc. Sell -2.51% -5.58%
The percentage of cash held in the portfolio is: 3.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACRS Buy All -6.72%
HAE Buy All -6.69%
Assets Rebalanced
Asset Action Weight
PTGX Sell -1.39%
ENTA Sell -1.57%
THC Sell -1.21%
RCM Sell -1.21%
BRKR Sell -1.82%
RDNT Sell -1.94%
2024-03-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.66% 12.49%
NUTX Nutex Health Inc. Buy 12% -6.56%
RCM R1 RCM Inc. Buy 13.09% 25.25%
PTGX Protagonist Therapeutics, Inc. Buy 12.87% 11.13%
THC Tenet Healthcare Corporation Buy 12.82% -0.63%
MRSN Mersana Therapeutics, Inc. Buy 12.49% -3.2%
ENTA Enanta Pharmaceuticals, Inc. Buy 13.15% 1.95%
RDNT RadNet, Inc. Buy 13.62% 5.61%
NTRA Natera, Inc. Buy 13.01% 0.89%
QTRX Quanterix Corporation Buy 11.17% 0%
HAE Haemonetics Corporation Sell -5.31% -4.3%
SAGE Sage Therapeutics, Inc. Sell -12.23% 6.45%
TDOC Teladoc Health, Inc. Sell -7.28% 5.82%
CUTR Cutera, Inc. Sell -2.58% -9.14%
ACRS Aclaris Therapeutics, Inc. Sell -2.48% -5.04%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • QTRX
Assets Removed
Asset Action Perf %
RVNC Sell All -14.99%
Assets Rebalanced
None
2024-03-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.33% 10.34%
NUTX Nutex Health Inc. Buy 11.84% -7.38%
RCM R1 RCM Inc. Buy 13.04% 25.34%
PTGX Protagonist Therapeutics, Inc. Buy 13.01% 12.89%
RVNC Revance Therapeutics, Inc. Buy 12.58% -2.24%
THC Tenet Healthcare Corporation Buy 12.84% 0%
MRSN Mersana Therapeutics, Inc. Buy 12.84% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 12.84% 0%
RDNT RadNet, Inc. Buy 12.84% 0%
NTRA Natera, Inc. Buy 12.84% 0%
HAE Haemonetics Corporation Sell -5.24% -3.43%
SAGE Sage Therapeutics, Inc. Sell -12.23% 6.06%
TDOC Teladoc Health, Inc. Sell -7.37% 4.09%
CUTR Cutera, Inc. Sell -2.87% -22.34%
ACRS Aclaris Therapeutics, Inc. Sell -2.45% -4.2%
The percentage of cash held in the portfolio is: 2.16%
New Assets Added
  • THC
  • MRSN
  • ENTA
  • RDNT
  • NTRA
Assets Removed
None
Assets Rebalanced
None
2024-03-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.07% 8.11%
NUTX Nutex Health Inc. Buy 11.85% -7.38%
RCM R1 RCM Inc. Buy 13.1% 25.78%
PTGX Protagonist Therapeutics, Inc. Buy 12.31% 6.67%
RVNC Revance Therapeutics, Inc. Buy 12.88% 0%
HAE Haemonetics Corporation Sell -5.16% -1.79%
SAGE Sage Therapeutics, Inc. Sell -12.03% 7.69%
TDOC Teladoc Health, Inc. Sell -7.42% 3.58%
CUTR Cutera, Inc. Sell -2.67% -13.71%
ACRS Aclaris Therapeutics, Inc. Sell -2.35% 0%
The percentage of cash held in the portfolio is: 66.42%
New Assets Added
  • RVNC
Assets Removed
Asset Action Perf %
CARA Sell All 32.4%
NVAX Sell All 14.88%
VRDN Sell All -7.24%
Assets Rebalanced
None
2024-02-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.04% 8.03%
NUTX Nutex Health Inc. Buy 11.73% -8.2%
RCM R1 RCM Inc. Buy 13.39% 28.83%
NVAX Novavax, Inc. Buy 10.37% 2.56%
CARA Cara Therapeutics, Inc. Buy 14.36% 38.63%
PTGX Protagonist Therapeutics, Inc. Buy 12.31% 6.85%
VRDN Viridian Therapeutics, Inc. Buy 13.2% 0%
HAE Haemonetics Corporation Sell -5.29% -4.42%
SAGE Sage Therapeutics, Inc. Sell -12.61% 3.09%
TDOC Teladoc Health, Inc. Sell -7.41% 3.52%
CUTR Cutera, Inc. Sell -2.35% 0%
ACRS Aclaris Therapeutics, Inc. Sell -2.35% 0%
The percentage of cash held in the portfolio is: 41.6%
New Assets Added
  • CUTR
  • ACRS
  • VRDN
Assets Removed
Asset Action Perf %
CUTR Sell All -32.07%
RGNX Sell All 36.58%
INGN Sell All -38.03%
Assets Rebalanced
None
2024-02-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 13.58% 37.41%
BRKR Bruker Corporation Buy 11.29% 4.56%
NUTX Nutex Health Inc. Buy 10.49% -8.2%
CUTR Cutera, Inc. Buy 11.83% -8.97%
INGN Inogen, Inc. Buy 11.92% -7.98%
RCM R1 RCM Inc. Buy 12.14% 30.53%
NVAX Novavax, Inc. Buy 12.65% 40%
CARA Cara Therapeutics, Inc. Buy 13.65% 47.35%
PTGX Protagonist Therapeutics, Inc. Buy 10.7% 3.9%
HAE Haemonetics Corporation Sell -4.69% -3.6%
SAGE Sage Therapeutics, Inc. Sell -11.35% 2.41%
TDOC Teladoc Health, Inc. Sell -6.66% 3.07%
The percentage of cash held in the portfolio is: 14.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATRI Sell All 0.86%
Assets Rebalanced
None
2024-02-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 13.29% 1.57%
RGNX REGENXBIO Inc. Buy 13.08% 25.88%
BRKR Bruker Corporation Buy 11.86% 4.43%
NUTX Nutex Health Inc. Buy 11.03% -8.2%
CUTR Cutera, Inc. Buy 12.16% -11.03%
INGN Inogen, Inc. Buy 12.46% -8.57%
RCM R1 RCM Inc. Buy 12.16% 24.35%
NVAX Novavax, Inc. Buy 12.16% 27.91%
CARA Cara Therapeutics, Inc. Buy 12.16% 24.77%
PTGX Protagonist Therapeutics, Inc. Buy 11.23% 3.69%
HAE Haemonetics Corporation Sell -4.86% -2.11%
SAGE Sage Therapeutics, Inc. Sell -11.9% 2.75%
TDOC Teladoc Health, Inc. Sell -6.83% 5.43%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Buy All 2.91%
NVTA Buy All 87.43%
Assets Rebalanced
Asset Action Weight
PTGX Sell -2.67%
CARA Sell -2.31%
RCM Sell -3.02%
NVAX Sell -3.45%
INGN Buy 1%
ATRI Buy 1.21%
CUTR Buy 1.71%
2024-02-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 11.13% 0.57%
RGNX REGENXBIO Inc. Buy 12.76% 19.49%
BRKR Bruker Corporation Buy 12.34% 5.77%
NUTX Nutex Health Inc. Buy 11.94% -3.28%
CUTR Cutera, Inc. Buy 9.99% -17.24%
NVAX Novavax, Inc. Buy 15.43% 23.02%
RCM R1 RCM Inc. Buy 12.46% -0.63%
INGN Inogen, Inc. Buy 11.35% -9.46%
CARA Cara Therapeutics, Inc. Buy 16.83% 41.28%
PTGX Protagonist Therapeutics, Inc. Buy 13.77% 0%
TVTX Travere Therapeutics, Inc. Sell -5.51% 3.87%
NVTA Invitae Corporation Sell -0.77% 86.53%
HAE Haemonetics Corporation Sell -5.02% -2.52%
SAGE Sage Therapeutics, Inc. Sell -11.89% 5.41%
TDOC Teladoc Health, Inc. Sell -6.88% 7.29%
The percentage of cash held in the portfolio is: 2.06%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
NTLA Sell All 3.2%
Assets Rebalanced
None
2024-02-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 13.41% 7.47%
ATRI Atrion Corporation Buy 11.02% -2.34%
RGNX REGENXBIO Inc. Buy 13.57% 24.71%
BRKR Bruker Corporation Buy 12.44% 4.61%
NUTX Nutex Health Inc. Buy 12.17% -3.28%
CUTR Cutera, Inc. Buy 11.2% -8.97%
NVAX Novavax, Inc. Buy 14.51% 13.49%
RCM R1 RCM Inc. Buy 12.75% -0.27%
INGN Inogen, Inc. Buy 11.8% -7.68%
CARA Cara Therapeutics, Inc. Buy 15.12% 24.45%
TVTX Travere Therapeutics, Inc. Sell -5.56% 4.84%
NVTA Invitae Corporation Sell -0.89% 84.85%
HAE Haemonetics Corporation Sell -5.21% -4.46%
SAGE Sage Therapeutics, Inc. Sell -12.25% 4.38%
TDOC Teladoc Health, Inc. Sell -7.36% 2.75%
The percentage of cash held in the portfolio is: 3.26%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
RGNX Buy 1.56%
2024-02-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 13.95% 6.29%
ATRI Atrion Corporation Buy 12.37% 4.18%
RGNX REGENXBIO Inc. Buy 12.8% 26.29%
NUTX Nutex Health Inc. Buy 12.8% -3.28%
CUTR Cutera, Inc. Buy 12.09% -6.55%
BRKR Bruker Corporation Buy 12.8% 2.34%
RCM R1 RCM Inc. Buy 12.85% -4.39%
NVAX Novavax, Inc. Buy 12.44% -7.44%
INGN Inogen, Inc. Buy 12.44% -7.49%
CARA Cara Therapeutics, Inc. Buy 13.45% 5.3%
TVTX Travere Therapeutics, Inc. Sell -5.86% 4.6%
NVTA Invitae Corporation Sell -1.03% 83.16%
HAE Haemonetics Corporation Sell -5.36% -2.19%
SAGE Sage Therapeutics, Inc. Sell -12.86% 4.6%
TDOC Teladoc Health, Inc. Sell -7.96% 0%
The percentage of cash held in the portfolio is: 5.07%
New Assets Added
  • TDOC
Assets Removed
Asset Action Perf %
EBS Buy All -64.24%
Assets Rebalanced
Asset Action Weight
CUTR Sell -1.57%
NUTX Sell -1.34%
RGNX Sell -1.96%
BRKR Sell -2.16%
NTLA Buy 1.95%
2024-02-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.57% 7.35%
ATRI Atrion Corporation Buy 11.58% 2.22%
RGNX REGENXBIO Inc. Buy 14.19% 27.25%
NUTX Nutex Health Inc. Buy 13.15% -5.74%
BRKR Bruker Corporation Buy 14.13% 1.31%
CUTR Cutera, Inc. Buy 14.1% 1.03%
RCM R1 RCM Inc. Buy 12.37% -3.58%
INGN Inogen, Inc. Buy 12% -6.5%
NVAX Novavax, Inc. Buy 12.32% -3.95%
CARA Cara Therapeutics, Inc. Buy 12.19% 0%
EBS Emergent BioSolutions Inc. Sell -5.38% 7.88%
TVTX Travere Therapeutics, Inc. Sell -5.88% -0.24%
NVTA Invitae Corporation Sell -1.11% 81.14%
HAE Haemonetics Corporation Sell -4.99% 0.38%
SAGE Sage Therapeutics, Inc. Sell -12.25% 4.73%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CARA
Assets Removed
Asset Action Perf %
MRSN Sell All -14.18%
Assets Rebalanced
None
2024-02-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.61% 9.69%
ATRI Atrion Corporation Buy 11.25% 1.11%
RGNX REGENXBIO Inc. Buy 14.16% 29.24%
MRSN Mersana Therapeutics, Inc. Buy 12.62% -10.17%
NUTX Nutex Health Inc. Buy 13.7% 0%
BRKR Bruker Corporation Buy 14.01% 2.21%
CUTR Cutera, Inc. Buy 13.85% 1.03%
RCM R1 RCM Inc. Buy 12.27% -2.69%
INGN Inogen, Inc. Buy 12.46% -1.18%
NVAX Novavax, Inc. Buy 12.19% -3.26%
EBS Emergent BioSolutions Inc. Sell -5.43% 5.45%
TVTX Travere Therapeutics, Inc. Sell -5.72% 0.73%
NVTA Invitae Corporation Sell -1.26% 78.11%
HAE Haemonetics Corporation Sell -4.96% -0.92%
SAGE Sage Therapeutics, Inc. Sell -12.63% 0%
The percentage of cash held in the portfolio is: 1.89%
New Assets Added
  • SAGE
Assets Removed
Asset Action Perf %
CARA Buy All -20.38%
Assets Rebalanced
None
2024-02-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.84% 12.57%
ATRI Atrion Corporation Buy 11.23% 1.57%
RGNX REGENXBIO Inc. Buy 13.78% 26.63%
MRSN Mersana Therapeutics, Inc. Buy 12.67% -9.22%
NUTX Nutex Health Inc. Buy 13.51% -0.82%
BRKR Bruker Corporation Buy 13.63% 0.06%
CUTR Cutera, Inc. Buy 13.76% 1.03%
RCM R1 RCM Inc. Buy 12.53% 0%
INGN Inogen, Inc. Buy 12.53% 0%
NVAX Novavax, Inc. Buy 12.53% 0%
EBS Emergent BioSolutions Inc. Sell -5.88% -3.03%
TVTX Travere Therapeutics, Inc. Sell -6.06% -5.81%
NVTA Invitae Corporation Sell -1.18% 79.46%
CARA Cara Therapeutics, Inc. Sell -13.16% -14.42%
HAE Haemonetics Corporation Sell -4.9% -0.25%
The percentage of cash held in the portfolio is: 3.17%
New Assets Added
  • RCM
  • INGN
  • NVAX
Assets Removed
Asset Action Perf %
AGEN Sell All -7.14%
Assets Rebalanced
None
2024-02-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.33% 11.82%
AGEN Agenus Inc. Buy 15.72% 32.56%
ATRI Atrion Corporation Buy 10.27% -3.57%
RGNX REGENXBIO Inc. Buy 12.08% 15.24%
MRSN Mersana Therapeutics, Inc. Buy 12.05% -10.4%
NUTX Nutex Health Inc. Buy 13.12% 0%
BRKR Bruker Corporation Buy 13.12% 0%
CUTR Cutera, Inc. Buy 13.12% 0%
EBS Emergent BioSolutions Inc. Sell -5.63% -2.42%
TVTX Travere Therapeutics, Inc. Sell -5.51% 0.12%
NVTA Invitae Corporation Sell -1.18% 78.68%
CARA Cara Therapeutics, Inc. Sell -12.04% -8.65%
HAE Haemonetics Corporation Sell -4.68% 0.64%
The percentage of cash held in the portfolio is: 28.23%
New Assets Added
  • NUTX
  • BRKR
  • CUTR
Assets Removed
Asset Action Perf %
LXRX Sell All 55.87%
Assets Rebalanced
None
2024-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.14% 4.59%
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.88% 37.56%
AGEN Agenus Inc. Buy 13.53% 8.57%
ATRI Atrion Corporation Buy 10.96% -2.04%
RGNX REGENXBIO Inc. Buy 12.13% 10.09%
MRSN Mersana Therapeutics, Inc. Buy 12.79% -9.46%
EBS Emergent BioSolutions Inc. Sell -5.56% 3.64%
TVTX Travere Therapeutics, Inc. Sell -5.6% 3.27%
NVTA Invitae Corporation Sell -1.95% 66.33%
CARA Cara Therapeutics, Inc. Sell -11.94% -2.5%
HAE Haemonetics Corporation Sell -4.95% 0%
The percentage of cash held in the portfolio is: 57.57%
New Assets Added
  • HAE
Assets Removed
Asset Action Perf %
ARCT Sell All 2.7%
SAVA Sell All -6.26%
SMTI Sell All -9.09%
CLDX Sell All -6.72%
Assets Rebalanced
None
2024-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.83% 17.08%
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.23% 37.09%
ARCT Arcturus Therapeutics Holdings Inc. Buy 13.03% 10.25%
AGEN Agenus Inc. Buy 13.68% 15.71%
ATRI Atrion Corporation Buy 11.87% 11.82%
CLDX Celldex Therapeutics, Inc. Buy 11.99% -0.58%
SMTI Sanara MedTech Inc. Buy 11.84% -1.84%
SAVA Cassava Sciences, Inc. Buy 13.53% -1.93%
RGNX REGENXBIO Inc. Buy 12.45% 19.15%
MRSN Mersana Therapeutics, Inc. Buy 12.45% -7.09%
EBS Emergent BioSolutions Inc. Sell -5.97% -9.09%
TVTX Travere Therapeutics, Inc. Sell -5.89% -7.26%
NVTA Invitae Corporation Sell -2.28% 58.47%
CARA Cara Therapeutics, Inc. Sell -12.39% -12.12%
The percentage of cash held in the portfolio is: 2.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
CUTR Buy All -27.2%
Assets Rebalanced
Asset Action Weight
ATRI Sell -1.35%
LXRX Sell -2.62%
RGNX Sell -1.92%
MRSN Sell -3.49%
SAVA Buy 0.63%
2024-02-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.15% 7.98%
NTLA Intellia Therapeutics, Inc. Buy 11.21% 8.62%
ATRI Atrion Corporation Buy 12.78% 5.75%
ARCT Arcturus Therapeutics Holdings Inc. Buy 12.14% 0.42%
AGEN Agenus Inc. Buy 12.08% 0%
SMTI Sanara MedTech Inc. Buy 12.83% 4.06%
RGNX REGENXBIO Inc. Buy 13.78% 11.81%
CLDX Celldex Therapeutics, Inc. Buy 12.23% -0.77%
SAVA Cassava Sciences, Inc. Buy 12.26% -0.59%
MRSN Mersana Therapeutics, Inc. Buy 17.54% 0%
EBS Emergent BioSolutions Inc. Sell -5.7% -1.82%
CUTR Cutera, Inc. Sell -6.23% -10.88%
TVTX Travere Therapeutics, Inc. Sell -5.64% -0.48%
NVTA Invitae Corporation Sell -1.13% 79.8%
CARA Cara Therapeutics, Inc. Sell -11.29% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CARA
  • MRSN
Assets Removed
Asset Action Perf %
PAHC Buy All -7.81%
Assets Rebalanced
None
2024-02-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.79% 0.94%
NTLA Intellia Therapeutics, Inc. Buy 11.01% 3.08%
ATRI Atrion Corporation Buy 13.21% 5.59%
ARCT Arcturus Therapeutics Holdings Inc. Buy 12.36% -1.19%
AGEN Agenus Inc. Buy 12.15% -2.86%
SMTI Sanara MedTech Inc. Buy 12.76% 0%
RGNX REGENXBIO Inc. Buy 12.76% 0%
CLDX Celldex Therapeutics, Inc. Buy 12.76% 0%
SAVA Cassava Sciences, Inc. Buy 12.76% 0%
EBS Emergent BioSolutions Inc. Sell -5.27% 9.09%
PAHC Phibro Animal Health Corporation Sell -5.8% -0.38%
CUTR Cutera, Inc. Sell -6.79% -16.74%
TVTX Travere Therapeutics, Inc. Sell -5.83% -0.24%
NVTA Invitae Corporation Sell -1.63% 71.94%
The percentage of cash held in the portfolio is: 14.76%
New Assets Added
  • SMTI
  • RGNX
  • CLDX
  • SAVA
Assets Removed
None
Assets Rebalanced
None
2024-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.6% 3.76%
NTLA Intellia Therapeutics, Inc. Buy 11.74% 5.06%
ATRI Atrion Corporation Buy 13.08% 0%
ARCT Arcturus Therapeutics Holdings Inc. Buy 13.08% 0%
AGEN Agenus Inc. Buy 13.08% 0%
EBS Emergent BioSolutions Inc. Sell -5.73% 5.45%
PAHC Phibro Animal Health Corporation Sell -6.15% -1.79%
CUTR Cutera, Inc. Sell -7.07% -16.32%
TVTX Travere Therapeutics, Inc. Sell -6.38% -4.96%
NVTA Invitae Corporation Sell -6.07% 0.11%
The percentage of cash held in the portfolio is: 68.82%
New Assets Added
  • ATRI
  • ARCT
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.77% -3.76%
NTLA Intellia Therapeutics, Inc. Buy 10.99% -1.78%
EBS Emergent BioSolutions Inc. Sell -5.63% 7.27%
PAHC Phibro Animal Health Corporation Sell -6.1% -0.85%
CUTR Cutera, Inc. Sell -6.09% 0%
TVTX Travere Therapeutics, Inc. Sell -6.09% 0%
NVTA Invitae Corporation Sell -6.09% 0%
The percentage of cash held in the portfolio is: 108.23%
New Assets Added
  • CUTR
  • TVTX
  • NVTA
Assets Removed
Asset Action Perf %
PTGX Sell All -8.8%
Assets Rebalanced
None
2024-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 9.72% -7.12%
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.14% 0%
NTLA Intellia Therapeutics, Inc. Buy 11.14% 0%
EBS Emergent BioSolutions Inc. Sell -5.93% 1.82%
PAHC Phibro Animal Health Corporation Sell -6.02% 0%
The percentage of cash held in the portfolio is: 79.95%
New Assets Added
  • PAHC
  • LXRX
  • NTLA
Assets Removed
None
Assets Rebalanced
None
2024-02-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 10.4% 0%
EBS Emergent BioSolutions Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 95.6%
New Assets Added
  • EBS
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2023-12-08 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All 32.47%
Assets Rebalanced
None
2023-12-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
MRSN Mersana Therapeutics, Inc. Buy 35.52% 38.31%
The percentage of cash held in the portfolio is: 64.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All -0.23%
SGRY Sell All 12.06%
AMEH Sell All -1.35%
Assets Rebalanced
None
2023-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 10.07% 1.48%
SGRY Surgery Partners, Inc. Buy 11.68% 17.66%
AMEH Apollo Medical Holdings, Inc. Buy 10.14% 2.23%
MRSN Mersana Therapeutics, Inc. Buy 34.16% 32.47%
The percentage of cash held in the portfolio is: 33.94%
New Assets Added
None
Assets Removed
Asset Action Perf %
CBAY Sell All 20.69%
SENS Sell All 18.74%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings